SOT 66th Annual Meeting and ToxExpo 2027
SOT 66th Annual Meeting and ToxExpo 2027 takes place on 14–17 March 2027 at Henry B. Gonzalez Convention Center, Texas. B2DB lists 425 speakers and 574 sessions announced so far.
The Society of Toxicology's 66th Annual Meeting and ToxExpo takes place March 14–17, 2027, at the Henry B. González Convention Center in San Antonio, Texas. The four-day meeting features continuing education courses, scientific sessions, posters, social events and a three-day ToxExpo exhibit hall (March 15–17) with companies, research organizations, government agencies, laboratory suppliers and consulting firms serving the toxicology community.
Key facts
| Dates | 14–17 March 2027 (upcoming) |
|---|---|
| Venue | Henry B. Gonzalez Convention Center, Texas, United States of America |
| Series | SOT Annual Meeting and ToxExpo |
| Speakers | 425 |
| Sessions | 574 |
| Stages | Undergraduate Event, Continuing Education Course, Special Event, Student and Postdoc Event, Scientific Session, Education-Career Advancement Session, Regional Interest Session, SOT Component Group Event, Informational Session, Engagement Session, Featured Session |
| Sponsors | 26 |
| Official site | toxicology.org/events/am/AM2027/schedule.asp |
Speakers (425)
Showing 400 of 425. Compiled from the published agenda; speakers can claim and verify their own entry.
- Dr. Abdel-Razak Kadry Adjunct Professor, University of Maryland School of Public Health
- Chao Ji Agency for Toxic Substances and Disease Registry;CDC/ATSDR
- Alison Harrill Corteva Agriscience
- Fenna Sillé Johns Hopkins University Center for Alternatives to Animal Testing (CAAT)
- Russell Thomas UL Research Institutes Chemical Insights;UL Research Institutes' Chemical Insights
- Gina Hilton PETA Science Consortium International e.V.
- Banrida Wahlang University of Louisville
- Barbara Kaplan Mississippi State University
- Helena Hogberg NIEHS/NICEATM
- Kan Shao Indiana University;Indiana University Bloomington
- Alexandra Noël Louisiana State University
- Chelsea Weitekamp UL Research Institutes Chemical Insights;UL Research Institutes' Chemical Insights
- Ilona Jaspers University of North Carolina at Chapel Hill
- Jodi Flaws University of Illinois at Urbana-Champaign;University of Illinois Urbana-Champaign
- Paul Deford Corteva Agriscience
- Shannon Bell RTI International
- Katie Paul Friedman UL Research Institutes' Chemical Insights;UL Research Institutes’ Chemical Insights
- Magdalini Sachana OECD;Organisation for Economic Co-operation and Development
- Richard Currie Syngenta, Jealott’s Hill International Research Center
- Terra Vincent-Hall NSF
- Xiaojia He UL Research Institutes' Chemical Insights
- Yu-Quan Wen AbbVie;AbbVie Inc.
- Agnes Karmaus Sciome LLC;Syngenta Crop Protection
- Amber Goetz Syngenta Crop Protection LLC
- Azita Cuevas Combe Inc.
- Cecilia Tan US EPA
- Cindy Lawler NIEHS
- Colette Miller US EPA
- Connie Chen HESI;HESI Global
- Crystal Cevering University of New Mexico
- Daniele Wikoff ToxStrategies LLC
- Darrell McCant Texas Commission on Environmental Quality
- David Leuthold Helmholtz Center for Environmental Research
- Donna Macmillan International Collaboration for Cosmetics Safety
- Eliane El Hayek University of New Mexico
- Emma Kasteel Universiteit Utrecht
- Heather Reddick Schaefer ToxStrategies LLC
- Jaime Ross University of Rhode Island
- Jithin George University of Rochester School of Medicine and Dentistry
- Kelly Coleman Medtronic
- Marie Bouressam Charles River Laboratories
- Marjory Moreau ESQlabs LLC;ESQlabs, LLC
- Pamela Lein University of California Davis
- Ranu Surolia University of Alabama at Birmingham
- Satya Achanta Duke University School of Medicine
- Srijit Seal Human Chemical Company
- Sumira Phatak University of New Mexico
- Udayan Apte University of Kansas Medical Center
- Weihsueh Chiu Texas A&M University
- William Klaren ToxStrategies LLC
- Yike Shen University of Texas at Arlington
- Yitong Liu US FDA
- Lara Lamon ESQlabs GmbH
- Nikolaos Georgiadis European Commission
- Connie Mitchell HESI
- Evelyn Reategui-Zirena Texas Commission on Environmental Quality
- Vladimir Bantseev Genentech
- Adrian Green Sciome LLC
- Alison Sanders University of Pittsburgh
- Amanda Jurgelewicz UL Research Institutes' Chemical Insights
- Anca Oana Docea University of Medicine and Pharmacy of Craiova
- Anna Lowit US EPA
- Anne Powell GE Healthcare
- Arun Singh GE Healthcare
- Brinda Mahadevan Brincor Associates LLC
- Changcheng Zhou University of California Riverside
- Christa Wright TeachWright Consulting LLC
- Christopher McPherson NIEHS/DTT
- Colleen McLoughlin Enhesa
- Elise Hickman University of North Carolina at Chapel Hill
- Emily Reinke General Dynamics Corporation
- Erik Tokar NIEHS
- Erin Huber RTI International
- Falgun Shah Merck & Co. Inc.
- Feng Gao University of California Los Angeles
- Fiona Sewell National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
- Flemming Cassee Rijksinstituut voor Volksgezondheid en Milieu (RIVM) and IRAS, Universiteit Utrecht
- Hao Chen Guangxi Medical University
- Ivan Rusyn Texas A&M University
- Janet Gould SafeBridge Consultants Inc.
- John Colbourne University of Birmingham
- Julia Boos Swiss Centre for Applied Human Toxicology
- Julia Tigges IUF—Leibniz Research Institute for Environmental Medicine
- Kellie Casavale Texas A&M AgriLife Research
- Kelly Salinas SRC Inc.
- Kenzie Pereira Applied Research Associates
- Kevin Boyd The Hershey Company
- Kylie Rock Clemson University
- Margaret Whittaker ToxServices LLC
- Mary Jacketti Applied Research Associates Inc.
- Matthew Linakis Ramboll Americas Engineering Solutions Inc.
- Matthew Linman Trinity Consultants
- Matthias Herzler Bundesinstitut für Risikobewertung (BfR)
- Maureen Bunger Altis Biosystems Inc.
- Melissa Wilkinson Defense Threat Reduction Agency
- Nicole Kleinstreuer NIH
- Nishad Jayasundara Duke University
- Patricia Ceger RTI International
- Paul Whaley Lancaster Environment Centre
- Qian Zhang UL Research Institutes' Chemical Insights
- Rachel Zemans University of Michigan
- Ruth Roberts ApconiX Ltd
- Shermaine Mitchell-Ryan HESI
- Shon Green Zelig Therapeutics
- Simon Kaja Loyola University Chicago
- Sol Bobst ToxSci Advisors
- Steven Van Cruchten University of Antwerp
- Warren Casey NIEHS
- Xian Wu East Carolina University
- Xiaoling Dai Abbott
- Xinrong Chen ABC Toxicology Consulting LLC
- Zachery Jarrell Emory University
- Zhichao Liu Boehringer Ingelheim
- Alema Idrizbegovic Merck & Co. Inc.
- Alexa Rizzolo Bristol Myers Squibb
- Alexandre Borrel Sciome LLC
- Amy Mihalchik ToxStrategies LLC
- Amy Roe Procter & Gamble
- Anika Dzierlenga NIEHS
- Annie Jarabek US EPA
- Anthony Luz US EPA
- Barbara Wetmore US EPA
- Beau Rollins Intrinsic Medical Group
- Bob Sonawane International Risk & Toxicology Institute LLC
- Brandy Riffle BASF Agricultural Solutions US LLC
- Brittany Baisch Enko Chem
- Catherine Christensen Solventum
- Catrin Hasselgren Genentech Inc.
- Cissy Li HESI
- Claire O'Brien Health and Environmental Sciences Institute (HESI)
- Cody Robarts Pfizer Inc.
- David Overall United Airlines
- David Reif NIEHS/DTT
- Derek Cissell Clarity Imaging Insights
- Devon Graham Florida State University College of Medicine
- Elaine Freeman Exponent
- Grace Patlewicz ToxStrategies LLC
- Heather Estrella Amgen
- Herve Lebrec HL Toxicology and Preclinical Services
- Hilmi Orhan Ege Üniversitesi, Turkey
- Hollie Skaggs Amgen
- Jenna Miller University of Michigan School of Public Health
- Jorge Muñiz Ortiz US Public Health Service
- Justin Teeguarden Pacific Northwest National Laboratory
- Kamin Johnson Corteva Agriscience
- Katrina Waters Pacific Northwest National Laboratory
- Kiara Fairman US FDA/NCTR
- Kym Gowdy Ohio State University
- Laurent Melherbe Eli Lily and Company
- Leah Wehmas US EPA
- Mark Nelms RTI International
- Matthew Gagne Heath Canada
- Melissa Giguere MG Giguere Forensics PLLC
- Natalia Vinas US EPA
- Philip Demokritou Rutgers School of Public Health
- Priscilla Lee US Army Combat Capabilities Development Command Chemical Biological Center
- Robert Nocco Independent Consultant
- Shagun Krishna Physicians Committee for Responsible Medicine
- Sylvia Sanchez Johns Hopkins University Bloomberg School of Public Health
- Troy Hubbard US FDA
- Victoria Yell CropLife America
- Vivek Lawana Namsa
- Wenyue (Wendy) Hu Vividion Therapeutics
- William Bisson Integrative Toxicology and Cancer Prevention
- Yong Qian NIOSH
- Zhanyun Wang University of Southern Denmark
- Mark Cronin Liverpool John Moores University
- Jinhee Choi University of Seoul
- A. Wallace Hayes University of South Florida
- Aaron Olson ARO Consulting
- Aarthi Narayanan George Mason University
- Abdullah Alnuqaydan Qassim University
- Adam Bettmann PETA Science Consortium International e.V.
- Ahna Brutlag SafetyCall International LLC
- Alan Hoberman Argus International
- Alessandra Tammaro Universiteit Leiden
- Alex Borrel Sciome LLC
- Alicia Bolt University of New Mexico
- Alistair Middleton Unilever
- Allen R. Kaczor Merck & Co. Inc.
- Allison Jenkins Texas Commission on Environmental Quality
- Amanda Kindt Railroad Commission of Texas
- Amie Lund University of North Texas
- Andres Cardenas Stanford University
- Andrew A. Rooney NIEHS
- Andrew Blakinger Eurofins Medical Device Testing
- Andrew Rooney NIEHS
- Anna Kreutz Applied Research Associates
- Annamaria Colacci Agency for Prevention, Environment, and Energy
- Anne Chappelle Trinity Consultants
- Ansley Elkins Clemson University
- April Kluever Independent Toxicologist
- Arianna Bassan Innovatune
- Aric Frantz AbbVie Inc.
- Arun Pandiri NIEHS/DTT
- Ashley Brinkman Central Garden & Pet Company
- Austin Martini Corteva Agriscience
- Bernard Zalc Sorbonne Université
- Bethany Pridgen The DEVAUS Group LLC
- Bette Meek University of Ottawa
- Blake Stutzman Active Education Forensics LLC
- Briana De Miranda University of Alabama at Birmingham
- Brigitte Lindeman Norwegian Institute of Public Health, Department of Chemical toxicology
- Bryan Vasser US EPA
- Carlie LaLone US EPA
- Carmen Williams NIEHS
- Carrie Price ToxStrategies, A BlueRidge Life Sciences Company
- Chang-ning Liu Pfizer Inc.
- Chris Gennings Icahn School of Medicine at Mount Sinai
- Christian Pellevoisin MatTek Life Sciences and Urbilateria
- Christie Sayes Baylor University
- Christina Tsitsimpikou General Chemical State Laboratory of Greece
- Christopher Duncan NIEHS
- Colin North BASF Corporation
- Corie Ellison Procter & Gamble
- Cristian Coarfa Baylor College of Medicine
- Dakota Robarts Pfizer Inc.
- Dalisa Kendricks NIEHS
- Dana Dolinoy University of Michigan School of Public Health
- Daniel Angelini US Army Combat Capabilities Development Command Chemical Biological Center
- Daniel Conklin University of Louisville
- Daniel Leventhal Tactyl Consulting
- David Faulkner California Department of Toxic Substances Control
- David Waxman Boston University
- Daysi Diaz-Diestra Gradient
- Deandra Grant Deandra Grant Law
- Deanna Luebker Solventum
- Deborah Smegal US FDA
- Doo Yeon Kim Massachusetts General Hospital, Harvard Medical School
- Douglas Walker Emory University
- Douglas Wolf WolfToxRisk LLC
- Ed Croom Haemonetics
- Edward Miller Schrödinger
- Elisa Passini National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
- Elisa Thépaut Ineris and National Technical University of Athens
- Elizabeth Figueroa Dark Horse Consulting Group
- Elizabeth Nuñez General Motors
- Ella Matischak Raptor Pharm & Tox Ltd.
- Ellen Fritsche Swiss Centre for Applied Human Toxicology
- Emanuela Corsini Università degli Studi di Milano
- Emily Hilz University of Texas at Austin
- Fjodor Melnikov Genentech Inc.
- Francis McCormack University of Cincinnati College of Medicine
- Fumito Mikashima Pharmaceuticals and Medical Devices Agency
- Giel Hendriks Toxys B.V.
- Grace Kuan Michigan Department of Environment, Great Lakes, and Energy
- Greg Warren Osmo Labs
- Gus Elizondo Texas A&M University
- Haiwei Gu Arizona State University
- Haiyan Tong US EPA
- Han-Hsuan D Tsai ExxonMobil Biomedical Sciences Inc.
- Hanan Ghantous US FDA
- Hannah Roe Texas A&M University
- Hannah Zierden University of Maryland
- Hao Zhu Tulane University
- Heather Enright Lawrence Livermore National Laboratory
- Heidi Bojes Texas Department of State Health Services
- Helen Booler Novartis AG
- Ilaria Merutka NIEHS
- Jaclyn Goodrich University of Michigan
- James Rathman Ohio State University
- Jason Stein University of North Carolina at Chapel Hill
- Jeanette Stingone Columbia University in the City of New York
- Jeffrey Card Intertek Clinical Research Services
- Jennifer Galvin Workplace Health Without Borders
- Jennifer Manilay University of California Merced
- Jessica Camacho US FDA
- Jessy Deshane University of Alabama at Birmingham
- Joao Barroso European Commission Joint Research Centre
- Jochem Louisse European Food Safety Authority
- Joel Cohen Gradient
- John Bender US FDA/CDRH
- John Troutman Procter & Gamble
- John Wambaugh ULRI Chemical Insights
- Joseph (Kip) Haney Texas Commission on Environmental Quality
- Joseph Carraway NAMSA
- Joseph Wu Stanford University
- Julia Rager University of North Carolina at Chapel Hill
- Junyeol Kim The Honest Company
- K. Michael Pollard Scripps Research Institute
- Kaitlyn Venneman University of Kansas Medical Center
- Kapil Bharti NIH
- Katherine A. James University of Colorado Anschutz Medical Campus
- Kathrin Schilling Columbia University
- Katie Przybylak Unilever Safety and Environmental Assurance Centre
- Keith Morris-Schaffer Exponent
- Keith Tanis Merck & Co. Inc.
- Kelly Carstens UL Research Institutes' Chemical Insights
- Kevin Schichlein University of North Carolina at Chapel Hill
- Kimberley Homan Genentech Inc.
- Kimberly Brannen Merck & Co.
- Knicki Bergman University of Rochester Medical Center
- Kristen Lyall Drexel University
- Kristin Eccles University of Ottawa
- Kristin Isaacs UL Research Institutes' Chemical Insights
- Kuen-Yuh Wu National Taiwan University
- Kyle Mandler NIOSH
- Kyung-Min Lim Ewha Womans University
- Lauren Duffy Environmental Working Group
- Lauren Middleton University of Michigan School of Public Health
- Lauren Mihalcik Aclairo Pharmaceutical Development Group
- Laurent Malherbe Eli Lilly and Company
- Leah Zorrilla Bayer Crop Science
- Lena Smirnova Johns Hopkins Bloomberg School of Public Health
- Lila Bazina Rutgers School of Public Health
- Lilia Iakoucheva University of California San Diego
- Linda Roberts NapaTox Consulting LLC (Retired)
- Livia Veress Icahn School of Medicine at Mount Sinai
- Lucian Farcal European Food Safety Authority
- Lyle Burgoon Raptor Pharm & Tox Ltd.
- Malek El Muayed SUNY Upstate Medical University
- Marco Corvaro Corteva Agriscience S.r.l. Italy
- Marcus Garcia University of New Mexico
- Maria Argos Boston University
- Marian Raschke Bayer AG
- Marianna Bacellar-Galdino Altasciences
- Martha Sandy California Office of Environmental Health Hazard Assessment
- Mary Paine Washington State University
- Mathew Dent Unilever
- Matias Attene-Ramos Bayer Crop Science
- Matthew Campen University of New Mexico
- Maureen Meister UL Research Institutes' Chemical Insights
- Megan Culbreth US FDA
- Megan Herting University of Southern California
- Megan LaFollette The North American 3Rs Collaborative
- Melanie Buser RHP Risk Management Inc.
- Michael Aschner Albert Einstein College of Medicine
- Michael Eppihimer US FDA/CDRH
- Mike DeVito US EPA
- Mirjam Luijten Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
- Mitzi Nagarkatti University of South Carolina School of Medicine
- Monique Perron US EPA
- Nakissa Sadrieh US FDA
- Naomi Kruhlak US FDA/CDER
- Nazanin Golbamaki L'oreal
- Neel Pasricha University of California San Francisco
- Neil Hukriede University of Pittsburgh
- Nikaeta Sadekar Research Institute for Fragrance Materials
- Norka Paden CDC/ATSDR
- Omari Bandele US FDA/OSCCS
- Patrick Ng UT Health San Antonio
- Paul Hanlon Abbott
- Peter Fantke Substitue ApS, Denmark & Goethe University
- Peter Theunissen Medicines Evaluations Board
- Phaedra Cole Zoetis
- Philip Hewitt Merck & Co. Inc.
- Philip Marx-Stoelting German Federal Institute for Risk Assessment
- Phillip Clapp University of North Carolina Chapel Hill
- Phoebe Stapleton Rutgers, The State University of New Jersey
- Rance Nault Michigan State University
- Randolph Ashton University of Wisconsin–Madison
- Ravi Persaud Apple Inc.
- Rebecca Clewell Air Force Research Laboratory
- Reo Kishi Pharmaceuticals and Medical Devices Agency (PMDA)
- Richard Kessler Fire Safety Research Institute of Underwriters Laboratories
- Rima Woods OEHHA
- Rita Strakovsky Michigan State University
- Robert (Yongbin) Zhang WuXi AppTec
- Robert Gunier Center for Environmental Research and Community Health
- Robert Roy Northland Toxicology Consultants LLC
- Ronald Wange Aclairo Pharmaceutical Development Group Inc.
- Ronnie Yeager AbbVie Inc.
- Rosemarie de la Rosa University of California Berkeley
- Sabine Lange Texas Commission on Environmental Quality
- Sachin Bhusari Coca-Cola Company
- Sara Gorman Freelance Author
- Sara Ruiz US Army Medical Research Institute of Infectious Diseases
- Sarah Obican University of South Florida
- Scott Boley Altasciences
- Sean Watford UL Research Institutes' Chemical Insights
- Sebastian Hoffman Institute of Evidence Based Toxicology
- Seiichi Ishida Sojo University/National Institute of Health Sciences
- Shadia Catalano Corteva Agriscience
- Shaligram Sharma UL Research Institutes' Chemical Insights
- Shannon Cousineau NSF
- Shaun McCullough RTI International
- Shoba Iyer San Francisco Environment Department
- Shuo Xiao Rutgers Ernest Mario School of Pharmacy
- Stephan Krieg Merck KgA
- Stephan Schaller ESQlabs GmbH
- Stephanie Engel University of North Carolina at Chapel Hill
- Stephanie Smith-Roe NIEHS
- Stephen Ndiritu Kennesaw State University
- Steven Hermansky US FDA
- Tamara Tal Helmholtz Centre for Environmental Research
- Tamiko Katsumoto Stanford University
- Thomas Knudsen Indiana University Bloomington
- Tim Malloy UCLA School of Law, Sustainable Technology and Policy Program
- Timo Wille Institut für Pharmakologie und Toxikologie der Bundeswehr
- Timothy Hickling Quasor LTD
- Timothy Zacharewski Michigan State University
- Vibha Jawa EpiVax
- Victor Johnson Burleson Research Technologies
- Vishal Vaidya Pfizer Research and Development
- Will Proctor GSK
- Xiaotong Wang University of Ottawa
- Xinxin Ding University of Arizona
- Yasumitsu Nishimura Kawasaki Medical School Department of Hygiene
- Zengmin Xia Abbott
- Ahmad Rahimi Chemva
Most represented companies
- US EPA — 14 speakers
- NIEHS — 13 speakers
- UL Research Institutes' Chemical Insights — 8 speakers
- US FDA — 8 speakers
- Texas Commission on Environmental Quality — 7 speakers
- University of New Mexico — 6 speakers
- University of North Carolina at Chapel Hill — 6 speakers
- Corteva Agriscience — 5 speakers
- Merck & Co. Inc. — 5 speakers
- RTI International — 5 speakers
Agenda (574 sessions)
Showing 500 of 574 sessions.
Day 1 — Saturday 13 March 2027
- Undergraduate Development Program: Check in for awardees 17:00–17:15 · Undergraduate Event
- Undergraduate Development Program: Opening Event 17:15–19:30 · Undergraduate Event
Day 2 — Sunday 14 March 2027
- SR01: Harmonized Benchmark Dose Modeling for Risk Assessment Decision-Making 07:00–07:45 · Continuing Education Course — Chao Ji, Kan Shao
- SR03: Running the Last Mile: A Playbook for Helping Your Research Get Noticed, Found, and Used 07:00–07:45 · Continuing Education Course — Shannon Bell, Paul Whaley, Andrew Rooney, Carrie Price
- SR02: On the Nerve: From Implantation Studies to Risk Assessment of High-Risk NeuroTech Medical Devices 07:00–07:45 · Continuing Education Course — Beau Rollins, Vivek Lawana, Daysi Diaz-Diestra, Joseph Carraway +1 more
- Bayesian Benchmark Dose (BMD) Modeling Across Data and Study Types: A Harmonized Strategy for Chemical Risk Assessment 07:05–07:25 · Continuing Education Course — Kan Shao
- The Importance of Getting Noticed 07:05–07:15 · Continuing Education Course — Shannon Bell
- Implementing Local and Systemic Endpoints in Large Animal Implantation Studies 07:15–07:25 · Continuing Education Course — Joseph Carraway
- Publication and Public Perspective: Sharing Your Research 07:15–07:25 · Continuing Education Course — Paul Whaley
- Toxicological Risk Assessment for Neural-Based Medical Devices 07:25–07:35 · Continuing Education Course — Daysi Diaz-Diestra
- From Data to Decisions: Benchmark Dose Modeling in Public Health 07:25–07:45 · Continuing Education Course — Chao Ji
- Systematic Review Search and Making Your Work Findable 07:25–07:35 · Continuing Education Course — Carrie Price
- Regulatory Review Perspectives on Neural Device Safety—Japan 07:35–07:45 · Continuing Education Course — Reo Kishi
- Rigor Reproducibility and Transparency—How to Publish Data That Gets Used for Decision-Making 07:35–07:45 · Continuing Education Course — Andrew Rooney
- Undergraduate Education Program: Toxicology Presentations 08:00–12:05 · Undergraduate Event
- AM06: Not Lost in Translation: Highlighting the Value of a Harmonized Language for Environmental Health to Support Risk Assessment Determinations 08:15–12:00 · Continuing Education Course — Annie Jarabek
- AM05: Effective Leadership for Complex Science Teams: Leveraging Observational Phenotyping to Improve Team Performance and Innovation in Toxicology 08:15–12:00 · Continuing Education Course — Justin Teeguarden, Katrina Waters
- AM04: Beyond the Black Box: Chemical Profiling, Grouping, and Read-Across with the OECD QSAR Toolbox 08:15–12:00 · Continuing Education Course — Alexandre Borrel, Shagun Krishna
- AM07: Operationalizing and Advancing New Approach Methods for Chemical Risk Assessment 08:15–12:00 · Continuing Education Course — Katie Paul Friedman, Barbara Wetmore
- AM09: Transcriptomic Point of Departure (tPOD): Basics to Bioinformatic Considerations 08:15–12:00 · Continuing Education Course — Connie Mitchell, Kamin Johnson
- AM08: Pulling Back the Curtain: AI/ML for Pharmaceutical Toxicologists with Hands-On Examples 08:15–12:00 · Continuing Education Course — Heather Estrella, Hollie Skaggs
- Undergraduate Development Program: Breakout Session for Advisors—Empowering Advisors of Future Toxicologists 13:05–14:00 · Undergraduate Event
- PM15: Welcome to the Jungle: An Overview of Botanicals and Considerations for Toxicity Testing 13:15–17:00 · Continuing Education Course — Amy Roe, Claire O'Brien
- PM13: Ocular Toxicity of Systemically Administered Therapeutics 13:15–17:00 · Continuing Education Course — Yu-Quan Wen, Vladimir Bantseev
- PM14: The Future Is Here: Practical Implementation of NAMs for Acute Toxicity 13:15–17:00 · Continuing Education Course — Brandy Riffle, Elaine Freeman
- Undergraduate Education Program: Breakout Sessions for Students—Planning for Graduate School: How to Get In and What to Expect? Graduate Student and Academic Advisor Perspectives 13:15–14:00 · Undergraduate Event
- PM10: AI for Safety and Regulatory Decision-Making: Building Trust, Transparency, and Translation in Toxicology 13:15–17:00 · Continuing Education Course — Srijit Seal, Kiara Fairman
- PM11: From NAMs to Regulatory Conclusions: Building and Evaluating IATAs for Neurotoxicity 13:15–17:00 · Continuing Education Course — Helena Hogberg, Magdalini Sachana
- PM12: Making the Most out of Read-Across: Successful Application of Global Guidance 13:15–17:00 · Continuing Education Course — Gina Hilton, Agnes Karmaus
- Undergraduate Education Program: Career Roundtables —Opportunities in Toxicology 14:10–15:10 · Undergraduate Event
- Undergraduate Education Program: Open Time with Academic Toxicology Program Directors, Internship Hosts, and SOT Special Interest Groups (SIGs) 15:15–17:00 · Undergraduate Event
- Awards Ceremony and Music 16:45–18:30 · Special Event
Day 3 — Monday 15 March 2027
- Chat with an Expert 09:00–16:30 · Student and Postdoc Event
- Poster Tours for Trainees 09:00–16:30 · Student and Postdoc Event
- Transforming Drug Discovery Using Agentic AI for Target Knowledge Reviews and Weight of Evidence Decision-Making 09:15–10:30 · Scientific Session — Zhichao Liu, Cody Robarts, Dakota Robarts, Sean Watford
- Phthalate Disruption of the Vaginal Epithelium: Mechanistic Insights into Barrier Dysfunction and Inflammation 09:15–09:30 · Scientific Session — Ansley Elkins
- Genomics, AI, and NAMs in Drug Discovery: Decision-Making and Career Pathways 09:15–09:30 · Education-Career Advancement Session — Joseph Wu
- The Vagina Monologues: Expanding Reproductive Toxicology to the Vaginal Interface 09:15–10:30 · Scientific Session — Kylie Rock, Ansley Elkins, Hannah Zierden, Kathrin Schilling +1 more
- Evolving Patterns of Multiorgan Toxicity Linked to Ultra-Potent Synthetic Opioids 09:15–09:30 · Scientific Session
- The Role of Toxicology in Oil and Gas Regulation: Protecting Health and the Environment at the Texas Railroad Commission 09:15–09:30 · Regional Interest Session — Amanda Kindt
- Introduction to the Usage of Agentic Workflows in Toxicology 09:15–09:35 · Scientific Session — Sean Watford
- Extracellular Vesicles as Mechanistic Mediators of Respiratory Toxicity 09:15–10:30 · Scientific Session — Elise Hickman, Hao Chen, Gus Elizondo, Haiyan Tong +1 more
- Emerging Toxicology of Illicit Opioids: From Overdose Pathophysiology to Organ Injury and Medical Countermeasures 09:15–10:30 · Scientific Session — Satya Achanta, Devon Graham, Livia Veress, Timo Wille
- Decision-Making Across the Drug Development Continuum: How Does It Align with Your Career Path? 09:15–10:30 · Education-Career Advancement Session — Xinrong Chen, Alema Idrizbegovic, Hanan Ghantous, Joseph Wu +2 more
- Federal and State Toxicologists Dancing the Texas Two-Step: Protecting the Environment and Public Health 09:15–10:30 · Regional Interest Session — Darrell McCant, Evelyn Reategui-Zirena, Amanda Kindt, Heidi Bojes +1 more
- Airway Extracellular Vesicles in Asthma: Imaging Flow Cytometry and Super Resolution Microscopy: Novel Tools for Characterization of EV-Mitochondrial Signaling Responses to Heavy Metal Exposure 09:15–09:30 · Scientific Session — Jessy Deshane
- Trainee Discussion with Plenary Session Speaker 09:30–10:30 · Student and Postdoc Event
- Modernizing Toxicology: Industry Decision-Making and Career Pathways 09:30–09:45 · Education-Career Advancement Session — Vishal Vaidya
- Taking Care of Texas: Real-World Risk Assessment and Emergency Response at TCEQ 09:30–09:45 · Regional Interest Session — Darrell McCant
- Circulating Extracellular Vesicles and Air Pollution Toxicity: Human Studies Evidence 09:30–09:45 · Scientific Session — Haiyan Tong
- Hidden Route of Exposure to Metals and PFAS via Vaginal and Vulvar Tissues 09:30–09:45 · Scientific Session — Kathrin Schilling
- Non-fatal Fentanyl Overdose Causes Acute Lung Injury and Multiorgan Damage 09:30–09:45 · Scientific Session — Livia Veress
- Enhancing Efficiency and Traceability by Applying Agentic Workflows to Target Knowledge Reviews 09:35–09:55 · Scientific Session
- Endocrine-Disrupting Chemicals as Drivers of Vaginal Dysbiosis 09:45–10:00 · Scientific Session — Hannah Zierden
- Integration of Environmental Health and Toxicology into Public Health Practice: Texas Department of State Health Services 09:45–10:00 · Regional Interest Session — Heidi Bojes
- Global Toxicology Services in Drug Development: Decision-Making and Career Pathways 09:45–10:00 · Education-Career Advancement Session — Robert (Yongbin) Zhang
- Respiratory EVs in Humans and Horses: Isolation Optimization, Proteomic Characterization, and Responses to Woodsmoke/Wildfire Smoke 09:45–10:00 · Scientific Session — Elise Hickman
- The Ultra-Potent Synthetic Opioid Carfentanil: Mechanism of Toxicity and Naltrexone and Antibodies as Potential Countermeasures 09:45–10:00 · Scientific Session — Timo Wille
- Integrating Data for Drug Discovery Decision-Making by Agent-Assisted Weight of Evidence Assessment 09:55–10:15 · Scientific Session — Zhichao Liu
- Tiny Tox Talk: SOT Maxxing: How to Get More Involved from an SOT Insider 10:00–10:20 · Special Event — Cynthia Rider
- Regulatory Toxicology: US FDA Decision-Making and Career Pathways 10:00–10:15 · Education-Career Advancement Session — Hanan Ghantous
- Resolving Exposure-Dependent Extracellular Vesicle Signaling in Airway Epithelial Models 10:00–10:15 · Scientific Session — Gus Elizondo
- Vaginal Microbiome Determinants and Relationship with Pregnancy Outcomes 10:00–10:15 · Scientific Session — Stephanie Engel
- Role of The Agency of Toxic Substances and Disease Registry in Emergency Response in Region 6 10:00–10:15 · Regional Interest Session — Norka Paden
- Potentiated Cardiopulmonary Toxicity of Fentanyl-Xylazine Co-exposure and Evaluation of Potential Medical Countermeasures 10:00–10:15 · Scientific Session — Satya Achanta
- Panel Discussion/Q&A: Emerging Toxicology of Illicit Opioids: From Overdose Pathophysiology to Organ Injury and Medical Countermeasures 10:15–10:30 · Scientific Session — Satya Achanta
- Panel Discussion/Q&A: Transforming Drug Discovery Using Agentic AI for Target Knowledge Reviews and Weight of Evidence Decision-Making 10:15–10:30 · Scientific Session — Dakota Robarts
- Panel Discussion/Q&A: Decision-Making Across the Drug Development Continuum: How Does It Align with Your Career Path? 10:15–10:30 · Education-Career Advancement Session — Xinrong Chen
- Panel Discussion/Q&A: The Vagina Monologues: Expanding Reproductive Toxicology to the Vaginal Interface 10:15–10:30 · Scientific Session — Kylie Rock
- Panel Discussion/Q&A: Extracellular Vesicles as Mechanistic Mediators of Respiratory Toxicity 10:15–10:30 · Scientific Session — Hao Chen
- Panel Discussion/Q&A: Federal and State Toxicologists Dancing the Texas Two-Step: Protecting the Environment and Public Health 10:15–10:30 · Regional Interest Session — Darrell McCant
- Tiny Tox Talk: Jumping on Moving Trains: Adapting to Industry as an Early Career Toxicologist 10:40–11:00 · Special Event — Sarah Carratt
- Predicting Secondary Pharmacology Is Accurate and Actionable by Combining Physics with AI Methods 10:45–11:00 · Scientific Session — Edward Miller
- Reimagining Reproductive and Developmental Toxicology: Stem Cell–Derived Organoid-Based New Approach Methodologies Across Windows of Susceptibility 10:45–12:00 · Scientific Session — Alexandra Noël, Erik Tokar, Xian Wu, Lena Smirnova +1 more
- Finding What You’re Looking For: Ocular Pathology of Systemically-Administered Therapeutics 10:45–11:00 · Scientific Session — Helen Booler
- AI Applications in Chemical Risk Assessment and Safety Science: Toward Predictive, Scalable, and Reduced Animal Testing Approaches 10:45–12:00 · Scientific Session — Chao Ji, Kan Shao, Srijit Seal, Edward Miller +1 more
- Brain and Heart Organoid Models for Investigating Early Developmental Toxicity and Biomarker Discovery 10:45–11:00 · Scientific Session — Erik Tokar
- Seeing the Side Effects: Ocular Toxicity Associated with Systemic Therapeutics 10:45–12:00 · Scientific Session — Yu-Quan Wen, Vladimir Bantseev, Chang-ning Liu, Helen Booler +2 more
- Translatability/Case Study: Development of Acute Mouse Model for Clinically Relevant Ocular Toxicity associated with ADCs 11:00–11:15 · Scientific Session — Ronnie Yeager
- Comparative Toxicology, Pathology, and Veterinary Specialty Section Mentoring Event 11:00–12:00 · SOT Component Group Event
- A Female Reproductive System-on-Chip to Advance Women’s Reproductive Health and Safety Research 11:00–11:15 · Scientific Session — Shuo Xiao
- Scaling New Approach Methodologies for AI-Driven Toxicology: High-Throughput Dermal Safety Assessment of Fragrance and Insecticidal Ingredients Using an OECD TG 439 Skin Irritation Platform 11:00–11:15 · Scientific Session — Greg Warren
- ToxDT: An Integrative Toxicity Digital Twin System for Toxicity Prediction and Experimental Design Optimization 11:15–11:30 · Scientific Session — Kan Shao
- Functional Brain Models: Organoid Intelligence for Neurodevelopment and Toxicity Testing 11:15–11:30 · Scientific Session — Lena Smirnova
- Crizotinib Reduces the Rate of Dark Adaptation in the Rat Independent of ALK Inhibition 11:15–11:30 · Scientific Session — Chang-ning Liu
- Tiny Tox Talk: Toxicology Without Barriers 11:20–11:40 · Special Event — Taehyun Roh
- iPSC-Derived 2D and 3D Outer Blood Retina Barrier to Assess Drug Toxicity 11:30–11:45 · Scientific Session — Kapil Bharti
- Agentic AI Combines Predictive Models and Published Evidence for Weight of Evidence Approaches in Chemical Risk Assessment 11:30–11:45 · Scientific Session — Srijit Seal
- Modeling Pulmonary Toxicity of Inhaled Particulate Matter and E-cigarette Aerosols Using Air-Liquid Interface and Lung Organoids Methodologies 11:30–11:45 · Scientific Session — Alexandra Noël
- Panel Discussion/Q&A: Seeing the Side Effects: Ocular Toxicity Associated with Systemic Therapeutics 11:45–12:00 · Scientific Session — Yu-Quan Wen
- Panel Discussion/Q&A: AI Applications in Chemical Risk Assessment and Safety Science: Toward Predictive, Scalable, and Reduced Animal Testing Approaches 11:45–12:00 · Scientific Session — Chao Ji
- Panel Discussion/Q&A: Reimagining Reproductive and Developmental Toxicology: Stem Cell–Derived Organoid-Based New Approach Methodologies Across Windows of Susceptibility 11:45–12:00 · Scientific Session — Xian Wu
- Nanoscience and Advanced Materials Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Comparative Toxicology, Pathology, and Veterinary Specialty Section Meeting/Lunch 12:00–13:30 · SOT Component Group Event
- Tiny Tox Talk: AI as Coworker? Putting Agentic AI to the Toxicology Test 12:40–13:00 · Special Event — Jessica Hanneman
- How Long is Long Enough? A Case Study on Exposure Requirements for Stability of tPODs and Concordance with Apical PODs 13:15–13:30 · Scientific Session — Austin Martini
- Reflections on a Global Understanding of Chemical Pollution 13:15–13:35 · Scientific Session — Zhanyun Wang
- Overview of the Tumor-Immune Microenvironment Illustrated by the Effects of Heavy Metal Exposures on Macrophages 13:15–13:30 · Scientific Session — Lauren Middleton
- Neurotoxicity of Pristine and Aged Micro- and Nanoplastics: Effects on the Blood-Brain Barrier and Neuronal Function 13:15–13:30 · Scientific Session — Emma Kasteel
- Defining the Chemical Universe for Understanding Chemical Safety 13:15–14:30 · Scientific Session — Katie Paul Friedman, Matthew Gagne, Zhanyun Wang, Kristin Isaacs +1 more
- Methods and Strategies to Advance the Safety and Regulatory Compliance of Consumer and Nonconsumer Products Sold in the United States Using Hazard-Based or Risk-Based Approaches 13:15–14:30 · Informational Session — Terra Vincent-Hall, Margaret Whittaker, Lauren Duffy, Martha Sandy +1 more
- Transcriptomics, Beyond Concept to Utilization: Practical Considerations and Successes for Regulatory Applications 13:15–14:30 · Scientific Session — Paul Deford, Leah Wehmas, Austin Martini, Kaitlyn Venneman
- How Do Chemical Exposures Affect the Tumor-Immune Microenvironment? 13:15–14:30 · Scientific Session — Richard Currie, Jenna Miller, Arun Pandiri, Lauren Middleton +2 more
- Micro- and Nanoplastics in the Brain: From Exposure to Neural Function 13:15–14:30 · Scientific Session — Emma Kasteel, Anika Dzierlenga, Haiwei Gu, Lilia Iakoucheva +1 more
- Developing a Hazard-based Cleaning Products Certification Standard to Advance Worker Safety, Consumer Health, and Environmental Protection 13:15–13:30 · Informational Session — Lauren Duffy
- Tiny Tox Talk: Let’s Give Them Something to Tox About 13:20–13:40 · Special Event — Angela Curry
- From Environmental Aging to Biological Impact: Understanding Micro- and Nanoplastic Uptake in Neurodegenerative Disease 13:30–13:45 · Scientific Session — Marcus Garcia
- Identification of MIE-Specific Gene Signatures Using Knockout Rat Models to Support Short-Term Assessment of Liver Carcinogenicity 13:30–13:45 · Scientific Session — Kaitlyn Venneman
- Environmental Exposures Rewire Tumor-Permissive Niches in Hepatocarcinogenesis 13:30–13:45 · Scientific Session — Arun Pandiri
- Best Practices for Establishing No Significant Risk Levels and Maximum Allowable Dose Levels for Use in California Safe Harbor Assessments and Safe Use Determination 13:30–13:45 · Informational Session — Martha Sandy
- Understanding the Exposure Data Landscape for Novel Chemical Entities 13:35–13:55 · Scientific Session — Kristin Isaacs
- Risk Screening Approaches for Impurities and Actives in Dietary Supplements and Nutraceuticals 13:45–14:00 · Informational Session — Shannon Cousineau
- Is the Tumorigenic Potential of TCDD Linked to Its Ability to Induce Myeloid-Derived Suppressor Cells? 13:45–14:00 · Scientific Session — Mitzi Nagarkatti
- Using Transcriptomics for Mechanistic Read-Across: Case Studies and Emerging Tools 13:45–14:00 · Scientific Session
- Modeling Fetal Brain Exposure to Polyethylene Nanoplastics Using Human Brain Organoids 13:45–14:00 · Scientific Session — Lilia Iakoucheva
- High-Throughput Toxicity Prediction and Functional Chemical Substitution 13:55–14:15 · Scientific Session — Peter Fantke
- Tiny Tox Talk: The Safety Trinity: What, How, and When of Cosmetic Assessment 14:00–14:20 · Special Event — Vivek Dadhania
- Metabolic Reprogramming Along the Gut-Brain Axis Due to MNPs Exposure 14:00–14:15 · Scientific Session — Haiwei Gu
- Understanding Consumer Product Safety Under the CPSC: Toxicity, Exposure, and Risk Assessment for Better Decision-Making 14:00–14:15 · Informational Session
- Asbestos-Induced Remodeling of Anti-Tumor Immune Surveillance: Immunotoxic Mechanisms, Mesothelioma Development, and Translational Biomarkers 14:00–14:15 · Scientific Session — Yasumitsu Nishimura
- US EPA’s Use of Five-Day Transcriptomic Data in Risk Evaluations to Fill Data Gaps for Chemicals with Incomplete Animal Data 14:00–14:15 · Scientific Session
- Panel Discussion/Q&A: Micro- and Nanoplastics in the Brain: From Exposure to Neural Function 14:15–14:30 · Scientific Session — Emma Kasteel
- Panel Discussion/Q&A: Transcriptomics, Beyond Concept to Utilization: Practical Considerations and Successes for Regulatory Applications 14:15–14:30 · Scientific Session — Paul Deford
- Panel Discussion/Q&A: Defining the Chemical Universe for Understanding Chemical Safety 14:15–14:30 · Scientific Session — Katie Paul Friedman
- Panel Discussion/Q&A: Methods and Strategies to Advance the Safety and Regulatory Compliance of Consumer and Nonconsumer Products Sold in the United States Using Hazard-Based or Risk-Based Approaches 14:15–14:30 · Informational Session — Margaret Whittaker
- Panel Discussion/Q&A: How Do Chemical Exposures Affect the Tumor-Immune Microenvironment? 14:15–14:30 · Scientific Session — Richard Currie
- Tiny Tox Talk: Muddy Boots, Clear Evidence: A Toxicologist’s Journey from Exposed Communities to Public Policy 14:40–15:00 · Special Event — Jesus Olivero-Verbel
- Opportunities and Challenges in Studying the Neural Exposome 14:45–15:00 · Scientific Session — Pamela Lein
- Occupational Exposure Limits: Translating Hazard Assessment Data on Reproductive and Developmental Toxicity to the Workplace 14:45–16:00 · Informational Session — Janet Gould, Robert Nocco, Alan Hoberman, Jennifer Galvin +1 more
- Perspectives in Science Communication from the Adverse Reactions Podcast 14:45–15:00 · Informational Session — Anne Chappelle
- Signals, Soundbites, and Science: Expanding the Landscape of Toxicology Communication 14:45–16:00 · Informational Session — Kelly Salinas, Anthony Luz, Anne Chappelle, David Faulkner +2 more
- Outcomes of Reproductive and Developmental Toxicity Studies 14:45–15:05 · Informational Session — Alan Hoberman
- Advancing Medical Device Safety with Human-Relevant New Approach Methodologies 14:45–16:00 · Scientific Session — Helena Hogberg, Kelly Coleman, Adam Bettmann, Christian Pellevoisin
- Welcome and Introduction 14:45–14:50 · Engagement Session — Russell Thomas
- In Vitro Irritation Testing for Medical Devices: A NAMs Success Story 14:45–15:00 · Scientific Session — Kelly Coleman
- Integrating Exposomics into Neurotoxicity Studies to Better Understand Mixtures and Cumulative Risk 14:45–16:00 · Scientific Session — Pamela Lein, Briana De Miranda, Ellen Fritsche
- Challenging the Status Quo: The History, Science, and Psychology Behind NAM Validation 14:45–16:00 · Engagement Session — Russell Thomas, Chelsea Weitekamp, Agnes Karmaus, Donna Macmillan +2 more
- When AI Contradicts Biology: How Should Toxicologists Respond? 14:45–16:00 · Engagement Session — Patricia Ceger, Mark Nelms, Andrew A. Rooney, Lyle Burgoon +1 more
- The Evolution of Validation and a Retrospective Analysis of the Validation Characteristics of OECD Human Health Test Guidelines 14:50–15:00 · Engagement Session — Warren Casey
- Flash Case Study: Data and LLM Integrity 14:50–15:05 · Engagement Session — Andrew A. Rooney
- Model Systems and Technological Advancements to Study the Neural Exposome 15:00–15:15 · Scientific Session
- Perspectives in Science Communication from the Adverse Reactions Podcast 15:00–15:15 · Informational Session — David Faulkner
- NAMs for Skin Sensitization Testing of Medical Devices 15:00–15:15 · Scientific Session — Christian Pellevoisin
- Insights Gained by Evaluating the Variability of In Vivo Toxicology Studies: Considerations for Validation and Performance Expectations of NAMs 15:00–15:10 · Engagement Session — Agnes Karmaus
- Flash Case Study: Biological and ’Omic Integrity 15:05–15:20 · Engagement Session — Rance Nault
- Physiology of Pregnancy and Lactation: Changes That Impact Targets and Exposure 15:05–15:25 · Informational Session — Linda Roberts
- Quantitative and Qualitative Concordance Between Clinical and Nonclinical Toxicity Data: Implications for NAM Performance Expectations 15:10–15:20 · Engagement Session — Chelsea Weitekamp
- Pyrogenicity in Medical Devices: Human-Relevant Testing and the Case Against Material Mediated Pyrogens 15:15–15:30 · Scientific Session — Adam Bettmann
- Integrating Cumulative Effects of The Exposome Across the Lifespan on Neurodegeneration 15:15–15:30 · Scientific Session — Briana De Miranda
- From Bench to Browser: Why Trainees Belong in Public Science Communication 15:15–15:30 · Informational Session — Knicki Bergman
- Framework and Interactive Workshop Lead 15:20–15:35 · Engagement Session — Lyle Burgoon
- Tiny Tox Talk: Meet the Director: Nicole Kleinstreuer, NIH/OD 15:20–15:40 · Special Event — Nicole Kleinstreuer
- Skin Sensitization as a NAM Validation Case Study: Lessons on Balancing Study Variability, Animal Studies, and Human Clinical Data 15:20–15:30 · Engagement Session — Donna Macmillan
- Risk Assessment and Communication Tools for Reproductive and Developmental Toxicity in the Workplace 15:25–15:45 · Informational Session — Jennifer Galvin
- Social Media as an Aid to Spreading Both Misinformation and Science Communication: A Pandemic Perspective 15:30–15:45 · Informational Session — Ed Croom
- From Innovation to Implementation: Accelerating Regulatory Use of New Approach Methodologies in Safety Assessment 15:30–15:45 · Scientific Session — Helena Hogberg
- Undergraduate Development Program: Host Mentor and Peer Mentor Meeting 15:30–16:25 · Undergraduate Event
- From the Exposome to Brain Disease: Rethinking Neurotoxicity in the Era of NAMs 15:30–15:45 · Scientific Session — Ellen Fritsche
- Addressing the Gap Between Evidence and Risk Perception: Lessons for Validation of Toxicological Models 15:30–15:40 · Engagement Session — Sara Gorman
- Interactive Session: When AI Contradicts Biology: How Should Toxicologists Respond? 15:35–16:00 · Engagement Session — Patricia Ceger
- Panel Discussion/Q&A: Challenging the Status Quo: The History, Science, and Psychology Behind NAM Validation 15:40–16:00 · Engagement Session — Russell Thomas
- Panel Discussion/Q&A: Advancing Medical Device Safety with Human-Relevant New Approach Methodologies 15:45–16:00 · Scientific Session — Kelly Coleman
- Panel Discussion/Q&A: Occupational Exposure Limits: Translating Hazard Assessment Data on Reproductive and Developmental Toxicity to the Workplace 15:45–16:00 · Informational Session — Janet Gould
- Panel Discussion/Q&A: Signals, Soundbites, and Science: Expanding the Landscape of Toxicology Communication 15:45–16:00 · Informational Session — Kelly Salinas
- Panel Discussion/Q&A: Integrating Exposomics into Neurotoxicity Studies to Better Understand Mixtures and Cumulative Risk 15:45–16:00 · Scientific Session — Pamela Lein
- Tiny Tox Talk: Meet the Director: Kyle Walsh/NIEHS 16:00–16:20 · Special Event — Kyle Walsh
- SOT/EUROTOX Debate: Artificial Intelligence in Toxicology Represents a Transformative Revolution Rather than a Cause for Caution 16:30–17:45 · Featured Session — Barbara Kaplan, Hilmi Orhan, Mark Cronin
- Panel Discussion: SOT/EUROTOX Debate: Artificial Intelligence in Toxicology Represents a Transformative Revolution Rather than a Cause for Caution 17:05–17:45 · Featured Session — Barbara Kaplan
- Immunotoxicology Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Carcinogenesis Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Ocular Toxicology Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Mixtures Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
Day 4 — Tuesday 16 March 2027
- Career Advancement Breakfast 07:30–09:00 · Special Event — Alexa Rizzolo, Troy Hubbard
- Bridging Internal and External Exposure: Leveraging Human Biomonitoring Data Through Physiologically Based Kinetic Modeling Toward Next-Generation Risk Assessment 08:00–09:15 · Scientific Session — Lara Lamon, Elisa Thépaut, John Wambaugh
- From Animals to Alternatives: Integrating and Validating MPS for Chemical and Biological Defense 08:00–09:15 · Scientific Session — Melissa Wilkinson, Priscilla Lee, Aarthi Narayanan, Daniel Angelini +2 more
- From Animal-Based to Human-Centered Risk Assessment: The Role of Physiologically-Based Pharmacokinetic Models and Human Biomonitoring Data 08:00–08:20 · Scientific Session — Lara Lamon
- Food Safety in the Real World: Why Cumulative Risk Matters 08:00–09:15 · Scientific Session — Heather Reddick Schaefer, Kellie Casavale, Colin North, Rita Strakovsky
- Utilizing a Multi-Organ Chip Platform to Evaluate the Efficacy of Antibiotic Candidates Against Bacteria 08:00–08:15 · Scientific Session — Daniel Angelini
- Ensuring Acceptable Pet Food Ingredients: Considerations and Strategies for Evaluating Ingredients in Companion Animal Food 08:00–08:15 · Informational Session — William Klaren
- Global Session: Harmonizing the Future of Toxicology: A Global Roadmap for Modernizing Safety Testing Through Multi-sector Collaboration 08:00–09:15 · Featured Session — Barbara Kaplan, Emanuela Corsini, Kyung-Min Lim, Megan LaFollette +1 more
- Navigating PFAS in Medical Device Safety: A Cross-Disciplinary Scientific Evaluation of Materials, Biological Safety, Product Stewardship, and Emerging Toxicological Approaches 08:00–09:15 · Informational Session — Xiaoling Dai, Catherine Christensen, Deanna Luebker, Michael Eppihimer +2 more
- PFAS Fluoropolymer in Medical Devices: History, Challenges, and Regulatory Outlook 08:00–08:15 · Informational Session — Robert Roy
- Disentangling Dietary Environmental Factors as Potential Contributors to Obesity 08:00–08:15 · Scientific Session — Colin North
- Sniffing Out the Danger: Safety Assessments for Companion Animals 08:00–09:15 · Informational Session — William Klaren, Ahna Brutlag, Ashley Brinkman, Phaedra Cole
- Immunogenicity Crystal Ball: Integrating In Silico and Experimental Strategies for Predictive Immunogenicity Risk Assessment 08:00–09:15 · Scientific Session — Falgun Shah, Laurent Melherbe, Daniel Leventhal, Laurent Malherbe +2 more
- In Vitro Landscape for Immunogenicity Prediction: Assay Platforms and Risk Assessment Integration 08:00–08:15 · Scientific Session — Laurent Malherbe
- A Harmonized Definition for New Approach Methodologies: Building Common Ground for Global Collaboration 08:05–08:10 · Featured Session — Megan LaFollette
- Threshold of Toxicological Concern: Nonanimal Systemic Safety Assessment of Botanical Extracts for Cosmetics 08:10–08:15 · Featured Session — Kyung-Min Lim
- Global Standardization and Multi-sector Collaboration for MPS Implementation: Perspectives from Japan 08:15–08:20 · Featured Session — Seiichi Ishida
- Dietary Predictors of Environmental Exposures: Methodological Considerations for Observational Studies Evaluating the Roles of Chemicals in Cardiometabolic Health 08:15–08:30 · Scientific Session — Rita Strakovsky
- Current Animal Model Efforts and Transition to Microphysiological Systems 08:15–08:30 · Scientific Session — Sara Ruiz
- Combining In Silico and In Vitro Immunogenicity Assessments: A Pathway to Full Predictive Capability 08:15–08:30 · Scientific Session — Timothy Hickling
- From Materials to Market: Advancing Medical Device Safety Through Product Stewardship 08:15–08:30 · Informational Session — Deanna Luebker
- Safety Testing Requirements and Evolving Regulatory Landscape for Pet Parasite Treatment Products 08:15–08:30 · Informational Session — Ashley Brinkman
- Physiologically Based Pharmacokinetic Modelling to Support Risk Assessment of Pyrethroid Exposure in Pregnant Women 08:20–08:40 · Scientific Session — Elisa Thépaut
- The European Perspective on Advancing Modern Safety Assessment Through Global Collaboration 08:20–08:25 · Featured Session — Emanuela Corsini
- Panel Discussion/Q&A: Global Session: Harmonizing the Future of Toxicology: A Global Roadmap for Modernizing Safety Testing Through Multi-sector Collaboration 08:25–09:15 · Featured Session — Barbara Kaplan
- Cumulative Risk Assessment Approaches for Food: A Case Study in Feasibility and Applicability to Low- and No- Calorie Sweeteners 08:30–08:45 · Scientific Session — Heather Reddick Schaefer
- Companion Animal Safety Assessments to Veterinary Pharmaceuticals 08:30–08:45 · Informational Session — Phaedra Cole
- The Immunogenicity Database Collaborative: A Public Resource-Enabling Data-Driven Immunogenicity Risk Assessment Decision 08:30–08:45 · Scientific Session — Daniel Leventhal
- Risk Based Biological Safety Assessment Strategies for PFAS Related Changes in Medical Devices 08:30–08:45 · Informational Session — Zengmin Xia
- Application of Complex In Vitro Microphysiological Systems to Model Pathology Resulting from Infections by RNA Viruses and Evaluate Countermeasure Effectiveness 08:30–08:45 · Scientific Session — Aarthi Narayanan
- A Systematic Approach to Exposure Inference from Human Biomonitoring Data 08:40–09:00 · Scientific Session — John Wambaugh
- Incorporating Regulatory Science Tools to Advance Safety of PFAS Used in Medical Devices 08:45–09:00 · Informational Session — Michael Eppihimer
- Monitoring for the Unexpected: Post-Market Surveillance and Adverse Event Reporting for Companion Animal Drugs and Pesticides 08:45–09:00 · Informational Session — Ahna Brutlag
- Human and Rat Neural Microphysiological Systems to Evaluate Threats and for Medical Countermeasure Assessment 08:45–09:00 · Scientific Session — Heather Enright
- Use of Human-Relevant In Silico and Cell-Based Assays to Understand Immune-Mediated Toxicities in Clinic 08:45–09:00 · Scientific Session — Vibha Jawa
- Multi-disciplinary Methods Development for Moving the Needle on Cumulative Risk Assessment in America 08:45–09:00 · Scientific Session — Kellie Casavale
- Panel Discussion/Q&A: Bridging Internal and External Exposure: Leveraging Human Biomonitoring Data Through Physiologically Based Kinetic Modeling Toward Next-Generation Risk Assessment 09:00–09:15 · Scientific Session
- Panel Discussion/Q&A: Food Safety in the Real World: Why Cumulative Risk Matters 09:00–09:15 · Scientific Session — Heather Reddick Schaefer
- Chat with an Expert 09:00–16:30 · Student and Postdoc Event
- Panel Discussion/Q&A: From Animals to Alternatives: Integrating and Validating MPS for Chemical and Biological Defense 09:00–09:15 · Scientific Session — Melissa Wilkinson
- Panel Discussion/Q&A: Sniffing Out the Danger: Safety Assessments for Companion Animals 09:00–09:15 · Informational Session — William Klaren
- Panel Discussion/Q&A: Immunogenicity Crystal Ball: Integrating In Silico and Experimental Strategies for Predictive Immunogenicity Risk Assessment 09:00–09:15 · Scientific Session — Falgun Shah
- Poster Tours for Trainees 09:00–16:30 · Student and Postdoc Event
- Panel Discussion/Q&A: Navigating PFAS in Medical Device Safety: A Cross-Disciplinary Scientific Evaluation of Materials, Biological Safety, Product Stewardship, and Emerging Toxicological Approaches 09:00–09:15 · Informational Session — Xiaoling Dai
- Tiny Tox Talk: Meet the Director: Angel Davey, CDMRP/TERP 09:20–09:40 · Special Event — Angel Davey
- Stressed Eggs: The Effects of Environmental Stressors on Telomeres During Embryonic Development 09:30–09:45 · Scientific Session — Carmen Williams
- Make New NAMs, Keep the Old: Advancing Physiological Relevance of Existing and Next-Generation NAMs Through Integrated Metabolism 09:30–10:45 · Scientific Session — Amanda Jurgelewicz, Kenzie Pereira, Giel Hendriks, Randolph Ashton
- Modernizing Developmental Immunotoxicity Testing: Reference Chemicals, Validation Criteria, and Mechanistic Frameworks 09:30–09:45 · Scientific Session — Victor Johnson
- Advancing Next-Generation Risk Assessment Through Bayesian Uncertainty Characterization 09:30–10:45 · Scientific Session — Chao Ji, Weihsueh Chiu, Mary Jacketti, Alistair Middleton +1 more
- Integrating Bayesian Approaches to Quantify Population Variability and Uncertainty in Next Generation Risk Assessment 09:30–09:45 · Scientific Session — Weihsueh Chiu
- Test Method Validation Frameworks and the Role of Readiness Criteria 09:30–09:50 · Informational Session — Joao Barroso
- Sex-Dependent Hepatic Regulatory Networks: From GH Programmed Epigenomes to Xenobiotic-Responsive lncRNAs 09:30–09:45 · Scientific Session — David Waxman
- Effects of Parental Exposure to Environmental Chemicals on the Development and Health of the Offspring 09:30–10:45 · Scientific Session — Jodi Flaws, Changcheng Zhou, Carmen Williams, Emily Hilz
- The Rewritable Liver: Environmental Exposures and the Erosion of Sexual Dimorphism 09:30–10:45 · Scientific Session — Banrida Wahlang, Colette Miller, David Waxman, Timothy Zacharewski
- Fixing the Implementation Gap: Best Practices for Validating a Test Method to Inform Regulatory Decision-Making 09:30–10:45 · Informational Session — Alison Harrill, Helena Hogberg, Joao Barroso, Megan Culbreth +1 more
- Advancing Developmental Immunotoxicity Testing: Defining Mechanistic Benchmarks and Human-Relevant Frameworks for Risk Assessment 09:30–10:45 · Scientific Session — Fenna Sillé, Julia Tigges, Brigitte Lindeman, Jennifer Manilay +1 more
- Chemical Bioactivity Assessment with In Vitro Metabolism Using Cell Painting and Transcriptomics 09:30–09:45 · Scientific Session — Amanda Jurgelewicz
- Immune Ontogeny and Hematopoietic Development as a Foundation for Developmental Immunotoxicity Testing 09:45–10:00 · Scientific Session — Jennifer Manilay
- Using Bayesian Inference to Support Uncertainty Informed Decision Making in Next Generation Risk Assessment: An Industry Perspective 09:45–10:00 · Scientific Session — Alistair Middleton
- Mechanisms of Sex Bias in Toxicant-Associated Liver Disease 09:45–10:00 · Scientific Session — Banrida Wahlang
- The Effects of Parental Exposure to Phthalates on Reproductive Outcomes in the Offspring 09:45–10:00 · Scientific Session — Jodi Flaws
- Optimizing S9 Metabolization Strategies to Strengthen Mechanistic In Vitro Genotoxicity Assessment 09:45–10:00 · Scientific Session — Giel Hendriks
- Applying Validation Best Practices to Develop an In Vitro Method to Evaluate Liver-Mediated Thyroid Effects for Safety Assessment of Pesticides 09:50–10:10 · Informational Session — Shadia Catalano
- RosetteArray Platform: DNT Hazard Screening with Incorporation of Simulated Human Metabolism 10:00–10:15 · Scientific Session — Randolph Ashton
- Early Life Ozone Exposure and Fetal Growth Restriction Alters Sex-Specific Developmental Trajectories in the Liver 10:00–10:15 · Scientific Session — Colette Miller
- Tiny Tox Talk: Dose-Response in Mentorship: Tailoring Your Guidance for Maximum Impact as a Mentor: Part A in Government and Industry 10:00–10:20 · Special Event — Ruth Roberts
- Establishing Developmental Immune Benchmarks: The Human Immune Development Map 10:00–10:15 · Scientific Session — Julia Tigges
- Reward Nuclei and Food Valuation as Neurobehavioral Substrates Through Which Environmental Endocrine Disruptors Promote Obesogenic Eating 10:00–10:15 · Scientific Session — Emily Hilz
- PoD Uncertainty Analysis Using Bayesian Copulas: A Case Study with NAMs and Dioxin 10:00–10:15 · Scientific Session
- Establishment of Developmental Neurotoxicity in vitro Battery Assays in a Naïve Laboratory 10:10–10:30 · Informational Session — Megan Culbreth
- Integrating Mechanistic Developmental Immunotoxicity into Human-Relevant Risk Assessment Frameworks 10:15–10:30 · Scientific Session — Brigitte Lindeman
- Paternal Epigenetic Inheritance: How Diets and Environmental Chemicals Shape Offspring Cardiometabolic Health 10:15–10:30 · Scientific Session — Changcheng Zhou
- Integrated Liver-Thyroid In Vitro System for Predicting Human-Relevant Thyroid Disruptors 10:15–10:30 · Scientific Session
- Loss of Hepatic Functional and Sexually Dimorphic Characteristics Following Persistent Aryl Hydrocarbon Receptor Activation by 2,3,7,8 Ttetrachlorodibenzo-p-dioxin 10:15–10:30 · Scientific Session — Timothy Zacharewski
- Making Bayesian Methods Usable for Toxicological Research: Practical Approaches for NGRA 10:15–10:30 · Scientific Session — John Troutman
- Panel Discussion/Q&A: Make New NAMs, Keep the Old: Advancing Physiological Relevance of Existing and Next-Generation NAMs Through Integrated Metabolism 10:30–10:45 · Scientific Session — Kenzie Pereira
- Panel Discussion/Q&A: Effects of Parental Exposure to Environmental Chemicals on the Development and Health of the Offspring 10:30–10:45 · Scientific Session — Jodi Flaws
- Panel Discussion/Q&A: Fixing the Implementation Gap: Best Practices for Validating a Test Method to Inform Regulatory Decision-Making 10:30–10:45 · Informational Session — Alison Harrill
- Panel Discussion/Q&A: The Rewritable Liver: Environmental Exposures and the Erosion of Sexual Dimorphism 10:30–10:45 · Scientific Session — Colette Miller
- Panel Discussion/Q&A: Advancing Developmental Immunotoxicity Testing: Defining Mechanistic Benchmarks and Human-Relevant Frameworks for Risk Assessment 10:30–10:45 · Scientific Session — Fenna Sillé
- Panel Discussion/Q&A: Advancing Next-Generation Risk Assessment Through Bayesian Uncertainty Characterization 10:30–10:45 · Scientific Session — Mary Jacketti
- Tiny Tox Talk: Immunosafety Careers: At the Interface of Innovative Discovery and Safety Assessment Risk 10:40–11:00 · Special Event — Tracey Papenfuss
- Retinoid Biology and the DARTable Genome: Establishing the Mechanistic Basis for DARTable Genome Prioritization 11:00–11:15 · Scientific Session — Thomas Knudsen
- Integrating New Data Streams into the Developmental Neurotoxicity In Vitro Battery 11:00–12:15 · Scientific Session — Magdalini Sachana, Christopher McPherson, Anna Kreutz, Kelly Carstens +1 more
- Sustainable Chemicals through Contemporary Toxicology Specialty Section Career Advancement 11:00–12:00 · SOT Component Group Event
- Particles, Exposure, and Nephrotoxicity: Emerging Insights into Inhalation-Induced Kidney Damage 11:00–12:15 · Scientific Session — Flemming Cassee, Alessandra Tammaro, Alicia Bolt, Katherine A. James
- Quantifying AOPs for Predictive Dev Tox: DARTable Genome and PBPK-Driven NAMs for Regulatory De-risking 11:00–12:15 · Scientific Session — Richard Currie, Shermaine Mitchell-Ryan, Allen R. Kaczor, Nazanin Golbamaki +1 more
- Overview of OECD Activities on Integration of DNT IVB and Zebrafish Assays for Chemical Assessment: Opportunities and Collaborative International Efforts 11:00–11:15 · Scientific Session — Magdalini Sachana
- Clinical and Translational Toxicology Specialty Section Mentoring Event 11:00–12:00 · SOT Component Group Event
- From Air Pollution to Kidney Disease: Early-Life Ultrafine Particle Exposure Drives Proximal Tubule Dysgenesis and Renal Vulnerability 11:00–11:15 · Scientific Session — Alessandra Tammaro
- Building the Exposure–Potency Foundation: The DARTable Genome Approach and the Need for PBPK Modeling 11:15–11:30 · Scientific Session — Allen R. Kaczor
- Integration of the Developmental Neurotoxicity In Vitro Battery to Inform Hazard Assessment 11:15–11:30 · Scientific Session — Kelly Carstens
- Short-Term Air Pollution (PM2.5) Exposure and Kidney-Related Emergent and Urgent Care Utilization in Rural and Urban Communities 11:15–11:30 · Scientific Session — Katherine A. James
- Tiny Tox Talk: The Toxicology of “It Depends”: What Does It Depend On? 11:20–11:40 · Special Event — Jesus Illan
- Analysis of Cardiometabolic and Inflammatory Biomarkers in People with Diabetes and Correlations with Exposure to Tungsten and Disease Outcomes 11:30–11:45 · Scientific Session — Alicia Bolt
- Data-Rich to Data-Poor: PBK Read-Across of Retinoids for NGRA-Based Internal Exposure Assessment 11:30–11:45 · Scientific Session — Nazanin Golbamaki
- The Zebrafish Visual and Acoustic Motor Response Assay has the Potential to Add Value to the Developmental Neurotoxicity In Vitro Battery 11:30–11:45 · Scientific Session — Tamara Tal
- Silica Deposits in Renal Tissue from a Chronic Kidney Disease of Unknown Etiology Hotspot Region 11:45–12:00 · Scientific Session
- In Vitro to In Vivo Extrapolation for the Extended Developmental Neurotoxicity In Vitro Battery to Support Developmental Neurotoxicity Hazard Human Health Risk Assessment Application 11:45–12:00 · Scientific Session — Anna Kreutz
- PBPK Modeling in Regulatory Decision-Making: Applications, Evidence Needs, and Implications for Developmental Safety 11:45–12:00 · Scientific Session
- Exposure Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Cardiovascular Toxicology Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Clinical and Translational Toxicology Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Panel Discussion/Q&A: Integrating New Data Streams into the Developmental Neurotoxicity In Vitro Battery 12:00–12:15 · Scientific Session — Christopher McPherson
- Panel Discussion/Q&A: Particles, Exposure, and Nephrotoxicity: Emerging Insights into Inhalation-Induced Kidney Damage 12:00–12:15 · Scientific Session — Flemming Cassee
- Panel Discussion/Q&A: Quantifying AOPs for Predictive Dev Tox: DARTable Genome and PBPK-Driven NAMs for Regulatory De-risking 12:00–12:15 · Scientific Session — Shermaine Mitchell-Ryan
- Sustainable Chemicals through Contemporary Toxicology Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Tiny Tox Talk: When Hazard Goes Viral: Perceived vs. Actual Risk in Food Safety 12:00–12:20 · Special Event — Christina Coric
- Tiny Tox Talk: AI Doesn’t Get You Off the Hook 12:40–13:00 · Special Event — Harshitha Nandula
- Two Species or Not Two Species? New Data to Re-evaluate Toxicology Testing Strategies Across the Sectors 13:00–14:15 · Scientific Session — Paul Deford, Cecilia Tan, Fiona Sewell, Ruth Roberts +2 more
- Industry Drivers, Practical Experiences, and Regulatory Challenges for Integrating NAMs in Food Ingredient Safety 13:00–13:20 · Scientific Session — Paul Hanlon
- The Use of NAMs in Food Safety: State of Practice and Opportunities for New Science 13:00–14:15 · Scientific Session — Ivan Rusyn, Kevin Boyd, Paul Hanlon, Steven Hermansky
- Cancer Risk: It’s Not a Straight Line 13:00–14:15 · Scientific Session — Gina Hilton, Anna Lowit, Douglas Wolf, Joseph (Kip) Haney +2 more
- Assessing the Role of Subchronic Dog Studies in Pesticide Risk Assessment: An EPA Retrospective Analysis 13:00–13:15 · Scientific Session — Cecilia Tan
- Revealing the Nanoplastics Dilemma: Biodistribution, Biological Effects, and Toxicological Implications for the Nervous System 13:00–14:15 · Scientific Session — Eliane El Hayek, Jaime Ross, Doo Yeon Kim, Matthew Campen +1 more
- Introduction: Applying NAMs and TAMs Frameworks to Identify Critical Windows and Mechanisms of Toxicant-Altered Kidney Development 13:00–13:15 · Scientific Session — Alison Sanders
- Differentiating In Utero and Lactational Exposure Pathways of Polyamide Micro- and Nanoplastics in Developing Rats 13:00–13:15 · Scientific Session — Phoebe Stapleton
- Nothing Happens Until the Signal Passes the Threshold 13:00–13:15 · Scientific Session — Douglas Wolf
- Kratom Craze: Science, Safety, and Regulation in the Age of Novel Products 13:00–14:15 · Scientific Session — Ilona Jaspers, Kym Gowdy, Ella Matischak, Kevin Schichlein +2 more
- Kratom in the ER: Case Reports on Kratom-Driven Medical Emergencies 13:00–13:15 · Scientific Session — Patrick Ng
- Environmental Metal Mixtures and Early Life Kidney Health: A NAMs-to-TAMs Framework for Informing Human Health Risk 13:00–14:15 · Scientific Session — Alison Sanders, Nishad Jayasundara, Chris Gennings, Ilaria Merutka +1 more
- Larval Zebrafish as a Scalable Model for Developmental Nephrotoxicity Screening: Translatable Functional and Mechanistic Insights Into Environmental Chemical Mixtures 13:15–13:30 · Scientific Session — Ilaria Merutka
- Unraveling Mechanisms Involved in Non-Genotoxic Carcinogenicity of Agrochemicals 13:15–13:30 · Scientific Session — Mirjam Luijten
- Past, Present, and Future: A Retrospective Analysis Towards Waiving Dog Testing for Agrochemicals 13:15–13:30 · Scientific Session — Paul Deford
- Pharmacokinetics and Clinical Trials of Kratom 13:15–13:30 · Scientific Session — Mary Paine
- Lifecyle of Micro- and Nanoplastics in the Body and Their Contribution to Alzheimer’s Disease 13:15–13:30 · Scientific Session — Jaime Ross
- Bridging Science and Regulation: US FDA's Collaborative Strategy for NAM Adoption in Food Ingredient Safety 13:20–13:40 · Scientific Session — Steven Hermansky
- Tiny Tox Talk: ToxSci Journal: Scientific Publishing Trends in the AI Era 13:20–13:40 · Special Event — Alison Harrill
- Breaking the Dogma: Are Two Species Still Necessary for Safety Assessment of Small Molecule Pharmaceuticals? 13:30–13:45 · Scientific Session — Elisa Passini
- Vaping Kratom and 7-OH Products: Emerging Trends and Toxicological Concerns 13:30–13:45 · Scientific Session — Kevin Schichlein
- Neurological Outcomes of Ingested Micro- and Nanoplastics in the LOAD3 Mouse Model of Dementia 13:30–13:45 · Scientific Session — Matthew Campen
- Human Kidney Organoids and Rodent Models for Assessing Developmental Kidney Toxicity: Lessons Gained from Tandem Approaches 13:30–13:45 · Scientific Session — Neil Hukriede
- Can Short-Term Transcriptomics Provide Enough Information for Cancer Risk Assessment? An Industry Case Study 13:30–13:45 · Scientific Session — Marco Corvaro
- International Survey of Food Ingredient Manufacturers: Assessing NAM Readiness, Regulatory Confidence, and Harmonization Priorities 13:40–14:00 · Scientific Session — Ivan Rusyn
- Nonlinear Excess Risk is Expected for Carcinogens with Nonlinear Target Tissue Absorption 13:45–14:00 · Scientific Session — Joseph (Kip) Haney
- From Dogs to Digital: The Virtual Second Species Suite 'DigiDog' as a Translational Alternative for Chronic Toxicity Assessment 13:45–14:00 · Scientific Session — Stephan Schaller
- Navigating the Toxicological and Legal Labyrinth of Kratom: Challenges in Detection, Causality, and Forensic Interpretation 13:45–14:00 · Scientific Session — Ella Matischak
- Micro- and Nanoplastics Exacerbate Amyloid-ß–Driven Tau Pathology via Astrocytes in Human 3D Alzheimer’s Disease Models 13:45–14:00 · Scientific Session — Doo Yeon Kim
- Translational Framework for Environmental Mixtures on Kidney Development and Injury 13:45–14:00 · Scientific Session — Chris Gennings
- Panel Discussion/Q&A: The Use of NAMs in Food Safety: State of Practice and Opportunities for New Science 14:00–14:15 · Scientific Session — Kevin Boyd
- Panel Discussion/Q&A: Kratom Craze: Science, Safety, and Regulation in the Age of Novel Products 14:00–14:15 · Scientific Session — Ilona Jaspers
- Panel Discussion/Q&A: Two Species or Not Two Species? New Data to Re-evaluate Toxicology Testing Strategies Across the Sectors 14:00–14:15 · Scientific Session — Fiona Sewell
- Panel Discussion/Q&A: Cancer Risk: It’s Not a Straight Line 14:00–14:15 · Scientific Session — Anna Lowit
- Tiny Tox Talk: Plot Twist: Your Toxicology Career May Not Go as Planned 14:00–14:20 · Special Event — Sydney Boney
- Panel Discussion/Q&A: Revealing the Nanoplastics Dilemma: Biodistribution, Biological Effects, and Toxicological Implications for the Nervous System 14:00–14:15 · Scientific Session — Jaime Ross
- Panel Discussion/Q&A: Environmental Metal Mixtures and Early Life Kidney Health: A NAMs-to-TAMs Framework for Informing Human Health Risk 14:00–14:15 · Scientific Session — Nishad Jayasundara
- Tiny Tox Talk: The Road Not Taken: From Academia to Consulting 14:40–15:00 · Special Event — Ishita Virmani
- From Exposure to Outcome: Mechanistic Pathways in Autoimmune Diseases 15:00–16:15 · Scientific Session — Crystal Cevering, Sumira Phatak, Amie Lund, Jaclyn Goodrich +1 more
- Next-Generation Read-Across: Improved Understanding of Relevant Uncertainties 15:00–16:15 · Informational Session — Gina Hilton, Donna Macmillan, Mark Cronin, Hannah Roe +2 more
- Setting the Stage: Environmental Triggers for Autoimmune Disease 15:00–15:15 · Scientific Session — Crystal Cevering
- Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue 15:00–16:15 · Engagement Session — Connie Chen, Julia Boos, Fumito Mikashima, Kimberly Brannen +2 more
- Guardians of Public Health Volume 2: Emergency Response Case Studies 15:00–16:15 · Engagement Session — Evelyn Reategui-Zirena, Allison Jenkins, Grace Kuan
- Dietary Intake Assessment in Food Safety: Setting the Stage for Regulatory Decision-Making 15:00–15:15 · Scientific Session — Matthew Linman
- EFSA Guidance on the Use of Read Across for Chemical Safety Assessment: Implementing Uncertainty Assessment 15:00–15:15 · Informational Session — Lucian Farcal
- Data-Driven Computational Approaches to Complex Chemical Mixtures 15:00–16:15 · Scientific Session — Adrian Green, David Reif, Han-Hsuan D Tsai, Julia Rager
- Raising the Bar: Modern Intake Assessments and the New Regulatory Landscape for Food Ingredient Safety 15:00–16:15 · Scientific Session — Brinda Mahadevan, Matthew Linman, A. Wallace Hayes, Omari Bandele +1 more
- Improving the Basis for Characterizing Toxicological Similarity of Whole Mixture Toxicity Using Measures of Chemical-Specific Toxicity from Next Generation Risk Assessments 15:00–15:20 · Scientific Session
- Rethinking DART Testing: How Do We Really Advance Developmental Toxicity NAMs? 15:00–15:10 · Engagement Session — Connie Chen
- Save the Water, Save the Galaxy 15:05–15:10 · Engagement Session — Allison Jenkins
- Advancing Human Risk and Safety Assessment: An Academic Perspective on DevTox NAMs 15:10–15:20 · Engagement Session — Julia Boos
- Concurrent Workshops: Guardians of Public Health Volume 2: Emergency Response Case Studies 15:10–15:45 · Engagement Session — Grace Kuan
- Quantifying Uncertainty to Determine Acceptability in Read-Across Predictions for Data Gap Filling 15:15–15:30 · Informational Session — Mark Cronin
- Bridging Exposure and Toxicology: Ensuring Intake Assessments Support a Robust Safety Conclusion 15:15–15:30 · Scientific Session — A. Wallace Hayes
- Per- and Polyfluoroalkyl Substances and Systemic Lupus Erythematosus 15:15–15:30 · Scientific Session — Jaclyn Goodrich
- Tiny Tox Talk: Meet the Director: Nancy Beck, US EPA 15:20–15:40 · Special Event — Nancy Beck
- Applying Developmental Toxicity NAMs in Pharmaceutical Development: Building Regulatory Credibility 15:20–15:30 · Engagement Session — Kimberly Brannen
- AI/ML Approaches to Quantify Wildfire Mixtures Toxicity 15:20–15:40 · Scientific Session — Julia Rager
- Using NAMs to Build Confidence in Read-Across for Complex Mixtures: A Repeat-Dose Toxicity Case Study 15:30–15:45 · Informational Session — Katie Przybylak
- Characterizing Dietary Intake in Vulnerable and High Frequency Consumers: Industry Perspectives for Risk Assessment 15:30–15:45 · Scientific Session — Sachin Bhusari
- Inhaled Particulates as Triggers for Systemic Autoimmunity: Mechanistic Insights from Silica Dust Exposure and Rheumatoid Arthritis 15:30–15:45 · Scientific Session — K. Michael Pollard
- Developmental and Reproductive Toxicology NAMs: Regulatory Opportunities, Scientific Expectations, and Contexts of Use in Europe 15:30–15:40 · Engagement Session — Peter Theunissen
- Quantitative Compositional Similarity Assessment Using Constituent Hydrocarbon Blocks for Petroleum Substances 15:40–16:00 · Scientific Session — Han-Hsuan D Tsai
- Advancing DART NAMs: A PMDA Perspective on Regulatory Science, Weight-of-Evidence, and Global Harmonization 15:40–15:50 · Engagement Session — Fumito Mikashima
- Toxicology and Risk Communication Games: Catching Fire 15:45–16:10 · Engagement Session
- Exposure and Autoimmunity: How Diesel Exhaust Particulate Disrupts the Gut-Immune Axis in Lupus 15:45–16:00 · Scientific Session — Amie Lund
- Raising the Bar from a Regulatory Perspective: Evaluating Exposure Evidence for Food Chemical Safety 15:45–16:00 · Scientific Session — Omari Bandele
- Navigating Uncertainty in Read-Across: Insights from Systematic Analysis of ECHA Regulatory Decisions 15:45–16:00 · Informational Session — Hannah Roe
- DART NAMs and Clinical Decision-Making: Interpreting Human Relevance for Pregnancy Counseling 15:50–16:00 · Engagement Session — Sarah Obican
- Panel Discussion/Q&A: From Exposure to Outcome: Mechanistic Pathways in Autoimmune Diseases 16:00–16:15 · Scientific Session — Crystal Cevering
- Panel Discussion/Q&A: Raising the Bar: Modern Intake Assessments and the New Regulatory Landscape for Food Ingredient Safety 16:00–16:15 · Scientific Session — Brinda Mahadevan
- Panel Discussion/Q&A: Rethinking DART Testing: Advancing Dev Tox NAMs Through Stakeholder Dialogue 16:00–16:15 · Engagement Session — Connie Chen
- Panel Discussion/Q&A: Data-Driven Computational Approaches to Complex Chemical Mixtures 16:00–16:15 · Scientific Session — Adrian Green
- Panel Discussion/Q&A: Next-Generation Read-Across: Improved Understanding of Relevant Uncertainties 16:00–16:15 · Informational Session — Gina Hilton
- Metals Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Biotechnology and Drug Discovery Toxicology Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- In Vitro and Alternative Methods Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Medical Device and Combination Product Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Neurotoxicology Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Risk Assessment Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Mechanisms Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
- Food Safety Specialty Section Meeting/Reception 18:00–19:30 · SOT Component Group Event
Day 5 — Wednesday 17 March 2027
- From Thresholds to Frameworks: The Evolution of TTC for Modern Safety Assessment 08:00–09:15 · Informational Session — Grace Patlewicz, Corie Ellison, James Rathman, Nikaeta Sadekar
- Errors in Forensic Toxicology Testing: Lessons From Real Casework 08:00–08:15 · Scientific Session — Aaron Olson
- US FDA Overview of the Cosmetics Regulatory Framework and Updates on the 2022 Modernization of Cosmetics Regulation Act 08:00–08:15 · Scientific Session — Deborah Smegal
- Large-Scale Lithium-Ion Battery Fire Events: Chemical, Elemental, and Exposure Hazards 08:00–09:15 · Informational Session — David Overall, Bryan Vasser, Elizabeth Nuñez, Richard Kessler +1 more
- Multiple Strategies to Leverage Existing Work to Understand Toxicant Contributors to Autism: Lessons from the Autism Data Science Initiative 08:00–09:15 · Informational Session — Cindy Lawler, Nicole Kleinstreuer, Douglas Walker, Jason Stein +1 more
- Occupational Exposure & Control in EV Lithium-Ion Battery Operations 08:00–08:15 · Informational Session — Elizabeth Nuñez
- Inhalation Safety Without Data: Where Is the Line? 08:00–08:20 · Informational Session — Nikaeta Sadekar
- The Evolving Landscape of QIVIVE Workflows: From Published Approaches to High-Throughput Application for Data-Poor Chemicals 08:00–08:20 · Scientific Session — Matthew Linakis
- Common Sources of Error in Forensic Toxicology: Lessons from Casework and Laboratory Practice 08:00–09:15 · Scientific Session — Sol Bobst, Melissa Giguere, Aaron Olson, Bethany Pridgen +2 more
- Comparative Approaches to Safety Evaluation of Cosmetics: Toxicological Paradigms, Risk Assessment Frameworks, and Regulatory Decision-Making 08:00–09:15 · Scientific Session — Dr. Abdel-Razak Kadry, Bob Sonawane, Abdullah Alnuqaydan, Deborah Smegal +2 more
- The Autism Data Science Initiative: Utilizing Large-Scale Data Resources to Advance Our Understanding of Exposomic Factors and Gene X Environment Interactions in Autism 08:00–08:15 · Informational Session — Cindy Lawler
- Quantitative In Vitro to In Vivo Extrapolation for Consideration in Chemical Safety Decisions: Bridging Platforms, Endpoints, and Regulatory Needs 08:00–09:15 · Scientific Session — Yitong Liu, Matthew Linakis, Jochem Louisse
- Lithium-Ion Batteries and EV Firefighting: Health Hazards and Firefighters’ PPE 08:15–08:30 · Informational Session — Richard Kessler
- Examining Joint Effects and Modification by Prenatal Diet in the Association Between Environmental Toxicant Exposures and Autism: Results from the ECHO Cohort 08:15–08:30 · Informational Session — Kristen Lyall
- Beyond Documentation Compliance: Why ISO 17025 Accreditation Cannot Ensure Scientific Validity in Forensic Testing 08:15–08:30 · Scientific Session — Bethany Pridgen
- Beyond Compliance: Evaluating Hidden Toxicological Risks of Cosmetic Ingredients in the GCC within the Global Regulatory Landscape 08:15–08:30 · Scientific Session — Abdullah Alnuqaydan
- Translating In Vitro Mechanistic Findings to In Vivo Toxicity Outcomes: An FDA Case Study 08:20–08:40 · Scientific Session — Yitong Liu
- Modernizing TTC for NGRA: Rationale and Development of an Internal Threshold Framework 08:20–08:40 · Informational Session — Corie Ellison
- Measurement Uncertainty in Forensic Toxicology: Common Errors and Misinterpretations 08:30–08:45 · Scientific Session — Blake Stutzman
- Using Internal Exposome-Metabolome Dynamics to Identify Environmental Determinants of Autism 08:30–08:45 · Informational Session — Douglas Walker
- Persistent Hazards Following Large Scale Lithium-Ion Battery Fires 08:30–08:45 · Informational Session — Bryan Vasser
- Safety Assessment of Hazardous Materials in Cosmetics Across Asian Countries 08:30–08:45 · Scientific Session — Kuen-Yuh Wu
- Towards Regulatory Application of QIVIVE of DNT IVB Data for Pesticide Active Substances in Europe 08:40–09:00 · Scientific Session — Jochem Louisse
- A Botanicals TTC Framework Built on a Novel Integrated NCS–Phytochemical Database 08:40–09:00 · Informational Session — James Rathman
- Common Prosecutorial Errors in Presenting Forensic Evidence 08:45–09:00 · Scientific Session — Deandra Grant
- Brain Organoid Modeling of Gene X Environment Interactions Relevant to Autism 08:45–09:00 · Informational Session — Jason Stein
- Integrated Safety Assessment Strategy: International Cosmetics Regulation Cooperation 08:45–09:00 · Scientific Session — Mathew Dent
- Inhalation and Potential Genotoxic Risks of Electric Vehicle Fire–Derived Particulate Extracts in Small Airway Epithelial Cells 08:45–09:00 · Informational Session — Shaligram Sharma
- Panel Discussion/Q&A: From Thresholds to Frameworks: The Evolution of TTC for Modern Safety Assessment 09:00–09:15 · Informational Session
- Chat with an Expert 09:00–16:30 · Student and Postdoc Event
- Panel Discussion/Q&A: Quantitative In Vitro to In Vivo Extrapolation for Consideration in Chemical Safety Decisions: Bridging Platforms, Endpoints, and Regulatory Needs 09:00–09:15 · Scientific Session — Yitong Liu
- Panel Discussion/Q&A: Common Sources of Error in Forensic Toxicology: Lessons from Casework and Laboratory Practice 09:00–09:15 · Scientific Session — Sol Bobst
- Panel Discussion/Q&A: Comparative Approaches to Safety Evaluation of Cosmetics: Toxicological Paradigms, Risk Assessment Frameworks, and Regulatory Decision-Making 09:00–09:15 · Scientific Session — Dr. Abdel-Razak Kadry
- Panel Discussion/Q&A: Multiple Strategies to Leverage Existing Work to Understand Toxicant Contributors to Autism: Lessons from the Autism Data Science Initiative 09:00–09:15 · Informational Session — Cindy Lawler
- Panel Discussion/Q&A: Large-Scale Lithium-Ion Battery Fire Events: Chemical, Elemental, and Exposure Hazards 09:00–09:15 · Informational Session
- Poster Tours for Trainees 09:00–16:30 · Student and Postdoc Event
- Tiny Tox Talk: Meet the Director: Steven Musser, US FDA 09:20–09:40 · Special Event — Steven Musser
- Assessing the Impact of 3D Printing Operations Across a University Campus: A Collaborative Study Between Kennesaw State University and UL Research Institutes’ Chemical Insights 09:30–09:45 · Scientific Session — Stephen Ndiritu
- Introduction: Big Data for Environmental Health: From Exposures to Impact 09:30–09:45 · Scientific Session — Azita Cuevas
- Dietary Exposure to Cadmium, Lung Dysfunction, and Interactions with Dietary Chelators 09:30–09:45 · Scientific Session — Zachery Jarrell
- Beyond the Standard Battery: Revolutionizing Tox Testing in Drug Discovery with NAMs: A Cross-Industry Perspective 09:30–09:50 · Scientific Session — Kimberley Homan
- Harmonizing Weight of Evidence Assessments: The PRAGMATIC Framework for Global Chemical Safety Evaluation 09:30–10:45 · Scientific Session — Amber Goetz, Victoria Yell, Keith Morris-Schaffer, Monique Perron +1 more
- Harmonizing Weight of Evidence Assessments: A Conceptual Framework for Global Chemical Safety Evaluation 09:30–09:45 · Scientific Session — Amber Goetz
- Environmental Toxicology in the Era of Big Data: Using the CHAMACOS Cohort as a Model for Exposure Science and Advancing Risk Assessment 09:30–10:45 · Scientific Session — Azita Cuevas, Jorge Muñiz Ortiz, Andres Cardenas, Robert Gunier +1 more
- Occupational Exposure to 3D Printing Emissions and Potential Health Impacts 09:30–10:45 · Scientific Session — Qian Zhang, Yong Qian, Christie Sayes, Kyle Mandler +2 more
- Sustainable Chemistry in Electronics: From Supply Chain to Product Design 09:30–09:45 · Informational Session — Ravi Persaud
- Sustainable Chemistry Across Sectors: How Toxicology Informs Decisions in Electronics, Consumer Products, and Municipal Government 09:30–10:45 · Informational Session — Colleen McLoughlin, Junyeol Kim, Ravi Persaud, Shoba Iyer +1 more
- Metals on the Menu in the Exposome Era: How Dietary Metals Rewire Systemic Health 09:30–10:45 · Scientific Session — Xiaojia He, Zachery Jarrell, Malek El Muayed, Maria Argos
- From Innovation to Integration: Implementing NAMs for Human Risk Assessment in Drug Discovery Toxicology 09:30–10:45 · Scientific Session — Amy Mihalchik, Wenyue (Wendy) Hu, Kimberley Homan, Nakissa Sadrieh +2 more
- Personal Care Product Stewardship: Using Toxicology to Inform Ingredient Selection and Alternatives Evaluation 09:45–10:00 · Informational Session — Junyeol Kim
- Early-Life Environmental Exposures and Child Neurodevelopment: Evidence from the CHAMACOS Birth Cohort 09:45–10:00 · Scientific Session — Andres Cardenas
- It’s Complicated: How Sex, Diet and Metals Interact to Drive Liver Disease 09:45–10:00 · Scientific Session
- 3D Printing Filament Composition, Emissions, and the Induced Pro-inflammatory Responses 09:45–10:00 · Scientific Session — Christie Sayes
- Applying the PRAGMATIC Framework: A Case Study in Integrated Weight of Evidence Assessment for Endocrine Disruption 09:45–10:00 · Scientific Session — Keith Morris-Schaffer
- Cracking the Code: Using NAMs to Unmask Molecular Mechanisms of Toxicity and Bridge the Species Gap 09:50–10:10 · Scientific Session — Philip Hewitt
- Municipal Toxics Reduction in Practice: Precautionary Principle-Informed Decision-Making 10:00–10:15 · Informational Session — Shoba Iyer
- Tiny Tox Talk: Dose-Response in Mentorship: Tailoring Your Guidance for Maximum Impact as a Mentor: Part B in Academia 10:00–10:20 · Special Event — Jodi Flaws, Nathan Cherrington
- Maternal Nativity and Childhood Asthma Trajectories in the CHAMACOS Cohort 10:00–10:15 · Scientific Session — Rosemarie de la Rosa
- Dietary Zinc and Type 2 Diabetes Mellitus: From Basic and Epidemiological Evidence to Interventions 10:00–10:15 · Scientific Session — Malek El Muayed
- Regulatory Implementation of Weight of Evidence Frameworks for Pesticide Assessments in the United States 10:00–10:15 · Scientific Session — Monique Perron
- Exposure to Volatile Organic Compound Emissions of a Dental 3D Printing Resin Elicits Oxidative Damage in a 3D Human Alveolar Tissue Model 10:00–10:15 · Scientific Session — Maureen Meister
- Breaking the Barriers: The Evolving Regulatory Perspective on NAMs Adoption 10:10–10:30 · Scientific Session — Nakissa Sadrieh
- Metal Mixtures and Thyroid Function in Children: Evidence from the Bangladesh Environmental Research in Children's Health Cohort 10:15–10:30 · Scientific Session — Maria Argos
- Structuring Trade-Offs in Sustainable Chemistry: MCDA in Alternatives Assessment 10:15–10:30 · Informational Session — Tim Malloy
- From Longitudinal Exposure Data to Translational Toxicology: Policy Impact and Community Empowerment in CHAMACOS 10:15–10:30 · Scientific Session — Robert Gunier
- Three-Dimensional (3D) Printing Emission–Induced Pulmonary Toxicity and Beyond 10:15–10:30 · Scientific Session — Kyle Mandler
- Regulatory Implementation of Next Generation Risk Assessment Strategies and Weight of Evidence Frameworks in the EU 10:15–10:30 · Scientific Session — Philip Marx-Stoelting
- Interactive Session 4: Case Studies and Panel Discussions: From Innovation to Integration: Implementing NAMs for Human Risk Assessment in Drug Discovery Toxicology 10:30–10:45 · Scientific Session — Will Proctor
- Panel Discussion/Q&A: Environmental Toxicology in the Era of Big Data: Using the CHAMACOS Cohort as a Model for Exposure Science and Advancing Risk Assessment 10:30–10:45 · Scientific Session — Azita Cuevas
- Panel Discussion/Q&A: Harmonizing Weight of Evidence Assessments: The PRAGMATIC Framework for Global Chemical Safety Evaluation 10:30–10:45 · Scientific Session — Amber Goetz
- Panel Discussion/Q&A: Metals on the Menu in the Exposome Era: How Dietary Metals Rewire Systemic Health 10:30–10:45 · Scientific Session — Xiaojia He
- Panel Discussion/Q&A: Occupational Exposure to 3D Printing Emissions and Potential Health Impacts 10:30–10:45 · Scientific Session — Qian Zhang
- Panel Discussion/Q&A: Sustainable Chemistry Across Sectors: How Toxicology Informs Decisions in Electronics, Consumer Products, and Municipal Government 10:30–10:45 · Informational Session — Colleen McLoughlin
- Tiny Tox Talk: Don’t Mess With Texas Air Quality: Using Toxicological and Risk Assessment Principles in Air Permitting 10:40–11:00 · Special Event — Stanley Aniagu
- Evolutionary Genomics as a Foundation for Cross-Species Prediction of Chemical Effects 11:00–11:20 · Scientific Session — John Colbourne
- QIVIVE: A NAMs-Powered Framework for Exposure and Risk Assessment 11:00–12:15 · Scientific Session — Shannon Bell, Cecilia Tan, Marjory Moreau, Bette Meek +1 more
- Silica, Asbestos, Metals, and Dust: Mechanisms of Lung Injury, Impaired Repair, and Disease 11:00–12:15 · Scientific Session — Ranu Surolia, Rachel Zemans, Francis McCormack, Xinxin Ding
- Common Pathways, Divergent Outcomes: Decoding Complexity in Chemical Carcinogenesis 11:00–12:15 · Scientific Session — Christa Wright, William Bisson, Alex Borrel, Annamaria Colacci +1 more
- The Intestine as a Gatekeeper for Oral Exposure: Physiology, Toxicology, and Preclinical Model Systems 11:00–11:15 · Scientific Session — Stephan Krieg
- Cross-Species Prediction of Chemical Effects Across Evolutionary and Biological Scales 11:00–12:15 · Scientific Session — David Leuthold, John Colbourne, Carlie LaLone
- Introduction to PBK Modeling and QIVIVE 11:00–11:15 · Scientific Session — Marjory Moreau
- Juvenile Minipigs for Pediatric Drug Development: An Overview of Comparative Organ System Development 11:00–11:15 · Informational Session — Steven Van Cruchten
- When Other Species Bail on You, Minipig to the Rescue: An Evidence-Based Alternative for DART and Juvenile Toxicology Programs 11:00–12:15 · Informational Session — Marie Bouressam, Steven Van Cruchten, Ronald Wange, Scott Boley
- How (Un-)Certain Is (Un-)Safe? Quantifying Uncertainty in the Era of NAMs and NGRA 11:00–12:15 · Scientific Session — Daniele Wikoff, Matthias Herzler, Mike DeVito, Sebastian Hoffman
- Uncertainty Assessment and Regulatory Challenges for Establishing “Safe Use” of Chemicals in the Era of NAMs and NGRA 11:00–11:15 · Scientific Session — Matthias Herzler
- Integrating Intestinal Biology into NAMs Across Sectors 11:00–12:15 · Scientific Session — Maureen Bunger, Philip Demokritou, Lila Bazina, Marian Raschke +2 more
- From Particle to Scar: Epithelial Injury, Failed Repair, and Fibrosis in Silica-Induced Lung Disease 11:00–11:15 · Scientific Session — Rachel Zemans
- Ethical, Legal, Forensics, and Societal Issues Specialty Section Mentoring Event 11:00–12:00 · SOT Component Group Event
- From Pathway Activation to Outcome Divergence: Integrating Exposure Metrics into NGRA Using PFOS as a Model System 11:05–11:25 · Scientific Session — Annamaria Colacci
- From Exposure to Disease: Cadmium Induced Efferocytosis Defects and Biomarkers of Impaired Lung Injury Resolution 11:15–11:30 · Scientific Session — Ranu Surolia
- Minipigs for DART Testing: Are Perceived Barriers Holding Back a Valuable Model? 11:15–11:30 · Informational Session — Marie Bouressam
- Validating and Implementing New Approach Methods in a Modernized Rapid Risk Assessment Process for Operational Exposures 11:15–11:30 · Scientific Session — Rebecca Clewell
- A Conceptual Model for Quantifying Uncertainty in NGRA 11:15–11:30 · Scientific Session — Sebastian Hoffman
- Intestinal Toxicity in Drug Development: Leveraging Human In Vitro Models at Bayer 11:15–11:30 · Scientific Session — Marian Raschke
- Tiny Tox Talk: Same Skills, New Sector: Life After Public Service 11:20–11:40 · Special Event — Nicole Olgun
- From Sequence to Structure: Predicting Chemical Susceptibility Across Species (tentative title) 11:20–11:40 · Scientific Session — Carlie LaLone
- Organizing Multiple Endpoints: Mapping ToxCast/Tox21 High-Throughput Screening Assays to Key Characteristics of Carcinogens 11:25–11:45 · Scientific Session — Alex Borrel
- Use of Minipigs for Juvenile Toxicology Studies 11:30–11:45 · Informational Session — Scott Boley
- Quantifying Uncertainty in NAM-Based Risk Assessment: Lessons from Comparative Case Studies 11:30–11:45 · Scientific Session — Daniele Wikoff
- Development of a Human Crohn's Disease Intestine-on-Chip Model for Investigating Micro-Nanoplastic Uptake, Translocation, and Inflammation 11:30–11:45 · Scientific Session — Lila Bazina
- Adverse Outcome Pathways: Supporting Regulatory Application of NAMs and QVIVE 11:30–11:45 · Scientific Session — Bette Meek
- Mining Dust Inhalation Exposure in a Mouse Model: Arsenic Toxicokinetics, Interactions with Mold Exposure, and Adverse Effects on the Lung 11:30–11:45 · Scientific Session — Xinxin Ding
- A Systems-Level Phenomics Framework for Mapping Functional Response Spaces Across Species 11:40–12:00 · Scientific Session — David Leuthold
- Embracing Uncertainty to Build Confidence in Mechanistic Risk Assessment 11:45–12:00 · Scientific Session — Shannon Bell
- Using Artificial Intelligence to Determine Cancer Risk After Early-Life Environmental Exposures 11:45–12:05 · Scientific Session — Cristian Coarfa
- Pulmonary Osteoclast-Like Cells in Silicosis and Asbestosis 11:45–12:00 · Scientific Session — Francis McCormack
- Exploration of NAM Uncertainty Using Comparison of Different Approaches to Transcriptomic POD 11:45–12:00 · Scientific Session — Mike DeVito
- Exploring the Use of In Vitro Models for Safety Assessment of Newly Expressed Proteins in GM Crops 11:45–12:00 · Scientific Session — Matias Attene-Ramos
- Regulatory Perspective on the Use of the Minipig as an Alternative Species for DART and Juvenile Toxicity Studies 11:45–12:00 · Informational Session — Ronald Wange
- Panel Discussion/Q&A: How (Un-)Certain Is (Un-)Safe? Quantifying Uncertainty in the Era of NAMs and NGRA 12:00–12:15 · Scientific Session — Daniele Wikoff
- Occupational and Public Health Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Tiny Tox Talk: Mind Your Own Business: What Academia Doesn't Teach You About Running a Lab 12:00–12:20 · Special Event — Elizabeth Bowdridge
- Panel Discussion/Q&A: Cross-Species Prediction of Chemical Effects Across Evolutionary and Biological Scales 12:00–12:15 · Scientific Session — David Leuthold
- Panel Discussion/Q&A: Silica, Asbestos, Metals, and Dust: Mechanisms of Lung Injury, Impaired Repair, and Disease 12:00–12:15 · Scientific Session — Ranu Surolia
- Panel Discussion/Q&A: Integrating Intestinal Biology into NAMs Across Sectors 12:00–12:15 · Scientific Session — Maureen Bunger
- Panel Discussion/Q&A: When Other Species Bail on You, Minipig to the Rescue: An Evidence-Based Alternative for DART and Juvenile Toxicology Programs 12:00–12:15 · Informational Session — Marie Bouressam
- Ethical, Legal, Forensics, and Societal Issues Specialty Section Meeting/Luncheon 12:00–13:30 · SOT Component Group Event
- Panel Discussion/Q&A: QIVIVE: A NAMs-Powered Framework for Exposure and Risk Assessment 12:00–12:15 · Scientific Session — Marjory Moreau
- Panel Discussion/Q&A: Common Pathways, Divergent Outcomes: Decoding Complexity in Chemical Carcinogenesis 12:05–12:15 · Scientific Session — Christa Wright
- Tiny Tox Talk: No Is a Complete Sentence: I’m Still Learning to Say It 12:40–13:00 · Special Event — Jennifer Plahovinsak
- Antibody-Drug Conjugate–Associated Ocular Toxicity: Mechanistic and Clinical Insights That Guide Toxicological Assessments 13:00–14:15 · Scientific Session — Simon Kaja, Cissy Li, Marianna Bacellar-Galdino, Neel Pasricha
- Exposome-Informed Approaches for Advancing Mechanistic Toxicology and Risk Assessment 13:00–14:15 · Scientific Session — Fenna Sillé, Sylvia Sanchez, Jinhee Choi, Dana Dolinoy
- Exposome-Informed Multi-Omics to Define Immune-Mediated Mechanisms of Toxicity 13:00–13:15 · Scientific Session — Fenna Sillé
- Rapid Toxicity Reference Values for Applied Regulatory Needs 13:00–14:15 · Scientific Session — Russell Thomas, Chelsea Weitekamp, Weihsueh Chiu, Rima Woods +1 more
- Professional Advantages of Computational Toxicology Research for Graduate Students 13:00–13:15 · Education-Career Advancement Session — Hao Zhu
- Advancing Airway Safety: Biocompatibility and Breathing Gas Pathway Devices 13:00–13:15 · Informational Session — Anne Powell
- Not So Black and White: Multimodal Insights into White Matter Toxicity Across the Lifespan 13:00–14:15 · Scientific Session — Jithin George, Derek Cissell, Bernard Zalc, Dalisa Kendricks +1 more
- Deriving Non-Cancer Inhalation Toxicity Values at Scale Using the Database-Calibrated Assessment Process 13:00–13:20 · Scientific Session — Russell Thomas
- Deleterious Consequences of Perfluoroalkyl Substances Exposure (Forever Pollutants) on Myelin Functions: A Potential Environmental Risk for Multiple Sclerosis 13:00–13:15 · Scientific Session — Bernard Zalc
- Antibody-Drug Conjugate-Associated Ocular Toxicity: Mechanistic and Clinical Insights That Guide Toxicological Assessments 13:00–14:15 · Scientific Session
- The Many Paths to a Career in Computational Toxicology 13:00–14:15 · Education-Career Advancement Session — Catrin Hasselgren, Arianna Bassan, Fjodor Melnikov, Hao Zhu +2 more
- Clearing the Canopy: Advancing Predictive Confidence in Respiratory In Vitro NAMs Through Model Characterization 13:00–14:15 · Scientific Session — Emily Reinke, Erin Huber, Phillip Clapp
- Clearing the Air: Challenges and Strategies for Analyzing Breathing Gas Pathway Devices 13:00–14:15 · Informational Session — Anne Powell, Arun Singh, Andrew Blakinger, Jeffrey Card +1 more
- Characterizing the Model: How Culture Conditions Shape Baseline Cell Morphology, Function, and Toxicological Response in Primary Human Airway Epithelial Cells 13:00–13:20 · Scientific Session — Phillip Clapp
- Bridging Clinical Experience with Antibody-Drug Conjugate Ocular Adverse Events with Toxicology Assessments 13:00–13:25 · Scientific Session — Neel Pasricha
- A Career Journey Through Computational Chemistry, Toxicology, and AI 13:15–13:30 · Education-Career Advancement Session — Arianna Bassan
- White Matter Integrity as a Key Target for Long-Term Deficits Associated with In Vivo Developmental Organophosphate Pesticide Exposure 13:15–13:30 · Scientific Session — Dalisa Kendricks
Organisers, sponsors and partners
Sponsors (26)
British Toxicology Society (BTS) · Altasciences · BASF · Gilead Sciences · Nelson Laboratories, LLC · SciQra · Charles River · ToxServices LLC · WuXi AppTec · American Industrial Hygiene Association (AIHA) · Eli Lilly and Company · DuPont · ToxStrategies LLC · Society of Environmental Toxicology and Chemistry · Society for Birth Defects Research and Prevention (BDRP) · J.S. Held · JOINN-Biomere · ACS Publications · SNBL · UL Research Institutes’ Chemical Insights · International Collaboration on Cosmetics Safety · American College of Toxicology (ACT) · Elsevier · Amgen · ITR Laboratories · SOT Endowment Fund
Exhibitors (199)
Exponent · Vitrocell Systems GmbH · Antech Diagnostics GLP · Axion Biosystems, Inc. · Scantox · Institute for In Vitro Sciences, Inc. · Union Biometrica, Inc. · Japanese Society of Toxicology (JSOT) · Evalueserve · cellQART made by SABEU · Lonza AG · Epithelix · MileCell Biotechnology Inc. · AsedaSciences · Battelle · SciPinion, LLC · Ramboll · Inotiv · QSAR Lab Ltd. · Saguaro Biosciences · GXP-Storage · Altasciences · International Union of Toxicology (IUTOX) · Aurigene Pharmaceutical Services Limited · Mattek - Now Part of Sartorius · SAI Infusion Technologies · AxiomBio, Inc. · EUROTOX 2027 · Revvity · BioSpyder Technologies, Inc. · Golden West Companies · CorDynamics · IIT Research Institute (IITRI) · ImmuONE · SAFE Pharmaceutical Services Corp · NeuroScience Assoc/NSA Labs · GV Research Platform Private Limited · Evidence Based Toxicology Collaboration · Smithers · Suburban Surgical Company · ATCC · DNTOX · Agilent Technologies · ESQlabs GmbH · Ramona Optics Inc. · ChemPartner · MIMETAS BV · TÜV SÜD · CBSET · Litron Laboratories · Ncardia Services B.V. · Cell Biologics · Lhasa Limited · Zoologix, Inc. · SciQra · NC3Rs · National Jewish Health · StageBio · Vimta Labs Limited · EPL, Inc. · Certara · Simulations Plus, Inc. · Charles River · ACROBiosystems · Körber Technologies Instruments GmbH · Miltenyi Biotec · Lomir Biomedical, Inc. · Pacific BioLabs, Inc. · JHU Center for Alternatives to Animal Testing · Japan Tissue Engineering Co., Ltd. · TOXPLUS · RTI International · Evotec SE · Southern Research · Pharmascience Inc. · L2 Consulting Inc. · ICE Bioscience · Resero Analytics · Cyprotex, an Evotec Company · innoVitro GmbH · Lovelace Biomedical · emka TECHNOLOGIES · Liveon Biolabs Private Limited · Alithea Genomics SA · STEMCELL Technologies · Worldwide Primates, Inc. · Concept Life Sciences · IDEXX BioAnalytics · Instech Laboratories · TissUse · Anivance AI Corporation · ToxServices LLC · Envol Biomedical · NAMSA · ANEWCRO, LLC · TOXI-COOP Toxicological Research Center · VivoTex LLC · Vipragen Bioscience Pvt Ltd · Exir Bio · IT4TOX · Frontage · Palladium BioLabs · Korea Institute of Toxicology · Data Sciences International (DSI) · Aragen Lifescience · Chemtos · HemoGenix Inc. · Nova Research Laboratories LLC · Sequani Limited · Penman Consulting BV · 28bio · Resolian · Metisox · SynVivo · Toxys · Hamamatsu Corporation · Sciome LLC · Hesperos Inc. · InSphero · Stantec · MedTec Biolab, Inc. · ToxStrategies LLC · Taylor and Francis · BioIVT · Safer Human Medicine · Elm Hill Labs · QTest Labs · Labcorp · Integrated Data Science Laboratory for Metabolomics and Exposomics · CALT-Bio · LifeNet Health LifeSciences · Society for Birth Defects Research and Prevention (BDRP) · JOINN-Biomere · Pharmaron · Medicilon · Hilltop Lab Animals Inc. · FlashPath Inc. · Avidity Science, LLC · BRF - Bioscience Research Foundation · Histofy Ltd · Genesis Drug Discovery and Development (GD3) · Society for Experimental Biology and Medicine · EMMS · Melton Lab Co., Ltd. · Greenfield Pathology Services, Inc. · SNBL · Marshall BioResources · INDIGO Biosciences, Inc. · JRF Global · VRL Laboratories · invitrolize · Altis Biosystems, Inc. · ApconiX · UL Research Institutes’ Chemical Insights · KreaMedica / KreaConnect · ERBC Group · Genoskin · AnaPath · KCI Biotech (Suzhou) Inc. · PhoenixBio · Molecular Devices · acCELLerate GmbH · Human Chemical · American Board of Toxicology (ABT) · MedChemExpress · Franklin Biolabs · Southwest Research Institute · NeoSome Life Sciences · Integral Consulting Inc. · MetaSystems Group, Inc. · Sinclair Bio Resources · Bit Bio Ltd · MultiCASE Inc. · Trinity Consultants Life Sciences · Absentia Labs · Bioneeds India Private Limited · Ellegaard Göttingen Minipigs A/S · ToxSci Advisors · CH Technologies (USA), Inc. · SenzaGen · CN Bio · Yashraj Biotechnology Limited · Toxicology Excellence for Risk Assessment (TERA) · Product Safety Labs · Instem · BSL Bioservice Scientific Laboratories Munich GmbH · KCAS Bio · Emulate · ITR Laboratories · SCIREQ an emka TECHNOLOGIES company · Toxiqua Ltd · Adgyl Lifesciences Pvt. Ltd. · FUJIFILM Cellular Dynamics, Inc. · vivoVerse · AlveoliX · WestChina-Frontier PharmaTech Co., Ltd. · PointCross Life Sciences · ClyrChem · Eurofins Discovery
Source: the published agenda. See how B2DB compiles its records.